Exhibit (2024-11-20)
- Date
- 2024-11-20
Summary
Doc 758-2 in Case 24-11217-BLS, filed November 20, 2024, contains the fee exhibits of K&E for its work for Vyaire Medical Inc. for legal services rendered through September 30, 2024. Exhibit A, a statement of fees and expenses by subject matter, totals 984.80 hours and $1,353,324.50, with Asset Sales/Section 363 Issues the largest matter at 493.10 hours and $679,253.50. Exhibit B lists the attorneys and paraprofessionals who worked during the Fee Period with their departments, rates, hours and fees. Exhibit C summarizes expenses totaling $7,859.33, including airfare, outside printing and legal research. Exhibit D sets out invoices and detailed time entries by matter, beginning with Corporate & Governance Matters and ending with Employee and Labor Matters.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Full text
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 1 of 120
EXHIBIT A
Statement of Fees and Expenses by Subject Matter
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 2 of 120
Total Total
Matter Total Fees Total
Matter Description Billed Expenses
Number Requested Compensation
Hours Requested
5 Corporate & Governance Matters 33.40 $46,564.00 N/A $46,564.00
6 Disclosure Statement/Plan/Confirmation 157.20 $205,240.50 N/A $205,240.50
7 DIP Financing and Cash Collateral 3.00 $3,815.00 N/A $3,815.00
Asset Sales/Section 363 Issues: Use, Sale 493.10 $679,253.50 $679,253.50
10 N/A
& Disposition of Property
11 Executory Contracts & Unexpired Leases 10.00 $14,052.50 N/A $14,052.50
12 Business Operations 27.00 $40,634.50 N/A $40,634.50
18 Insurance and Surety Matters 29.10 $46,107.00 N/A $46,107.00
20 Tax Matters 74.90 $107,726.00 N/A $107,726.00
21 Case Administration 24.90 $32,923.00 N/A $32,923.00
22 Retention - K&E 87.80 $100,920.00 N/A $100,920.00
23 Retention - Non-K&E 2.40 $3,108.00 N/A $3,108.00
24 Vendor Matters 4.00 $6,135.50 N/A $6,135.50
25 Litigation 4.00 $6,813.00 N/A $6,813.00
28 Creditors’ Committee Matters 3.40 $4,963.00 N/A $4,963.00
29 Employee and Labor Matters 30.60 $55,069.00 N/A $55,069.00
Totals: 984.80 $1,353,324.50 N/A $1,353,324.50
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 3 of 120
EXHIBIT B
Attorneys and Paraprofessionals’ Information
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 4 of 120
The K&E attorneys who rendered professional services in these cases during the
Fee Period are:
Hourly
Date of Hours Billed Fees Billed
Billing Rate
Attorney Name Position Department Admissi In this In this
on In this
Application Application
Application
ECEB - Executive
Rebecca H. Arnall Associate 2017 $1,265.00 1.50 $1,897.50
Compensation
Chris Ceresa Associate Restructuring 2020 $1,395.00 119.80 $167,121.00
Tiffani Chanroo Associate Restructuring 2021 $1,345.00 57.00 $76,665.00
Erica D. Clark Associate Restructuring 2019 $1,595.00 0.60 $957.00
ECEB -
Erin Davey Associate 2023 $975.00 5.80 $5,655.00
Labor/Employment
Jaina Desai Associate Restructuring 2023 $975.00 30.50 $29,737.50
Corporate -
Luke Finn Associate 2021 $1,345.00 103.70 $139,476.50
M&A/Private Equity
Technology & IP
Justin M. Garfinkle Associate 2022 $1,095.00 2.40 $2,628.00
Transactions
Emanuel Goetz Associate Taxation 2024 $750.00 17.30 $12,975.00
Palmer Gunderson Associate Taxation 2023 $995.00 50.90 $50,645.50
David Hackel Associate Restructuring 2023 $1,095.00 9.40 $10,293.00
Corporate -
Olivia Kaufmann Associate 2023 $1,095.00 3.50 $3,832.50
Healthcare
ECEB - Employee
Sooah Kim Associate 2022 $1,095.00 1.90 $2,080.50
Benefits
Sabrina Lieberman Associate Restructuring 2023 $975.00 31.30 $30,517.50
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 5 of 120
Hourly
Date of Hours Billed Fees Billed
Billing Rate
Attorney Name Position Department Admissi In this In this
on In this
Application Application
Application
Corporate -
Ruan J. Meintjes Associate 2022 $1,095.00 6.70 $7,336.50
Healthcare
Jai Mudhar Associate Restructuring 2022 $1,345.00 13.30 $17,888.50
Corporate -
Trent Nachbar Associate 2022 $1,265.00 15.80 $19,987.00
M&A/Private Equity
Corporate -
Dan O'Connor Associate 2021 $1,345.00 17.50 $23,537.50
M&A/Private Equity
Sarah Osborne Associate Restructuring 2023 $975.00 4.40 $4,290.00
Carolin Paus Associate Restructuring 2023 $750.00 40.20 $30,150.00
Joshua Raphael Associate Restructuring 2023 $1,095.00 60.70 $66,466.50
Adrian Salmen Associate Restructuring 2021 $1,265.00 6.60 $8,349.00
Seth Sanders Associate Restructuring 2021 $1,265.00 4.50 $5,692.50
Technology & IP
Scottie Shermetaro Associate 2018 $1,575.00 10.40 $16,380.00
Transactions
Alex Stephenson Associate Taxation 2022 $1,175.00 2.60 $3,055.00
Kyle Nolan Trevett Associate Restructuring 2020 $1,265.00 1.80 $2,277.00
ECEB -
Paul Vasiloff Associate 2021 $1,345.00 6.20 $8,339.00
Labor/Employment
Donatus Wang Associate Restructuring 2022 $960.00 15.20 $14,592.00
Quin Wetzel Associate Restructuring 2023 $975.00 11.40 $11,115.00
Ann-Kathrin
Associate Restructuring 2018 $1,070.00 8.80 $9,416.00
Ziegler
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 6 of 120
Hourly
Date of Hours Billed Fees Billed
Billing Rate
Attorney Name Position Department Admissi In this In this
on In this
Application Application
Application
Corporate -
Hendrik Braun Partner 2010 $1,145.00 3.50 $4,007.50
M&A/Private Equity
Bernadette Technology & IP
Partner 2013 $1,575.00 3.00 $4,725.00
Coppola Transactions
Hannah Crawford Partner Restructuring 2015 $1,595.00 4.40 $7,018.00
Antitrust/Competitio
Sion Davies Partner 2016 $1,575.00 0.60 $945.00
n
Tabitha J. De
Partner Litigation - General 2015 $1,435.00 3.40 $4,879.00
Paulo
Anthony M. Del Corporate -
Partner 2014 $1,595.00 1.40 $2,233.00
Rio Healthcare
Michael Ehret Partner Taxation 2001 $1,895.00 32.80 $62,156.00
Corporate -
Kate Hardey Partner 2003 $1,995.00 19.20 $38,304.00
Healthcare
Partha Kar Partner Restructuring 2002 $2,305.00 0.50 $1,152.50
Alisa Melekhina Partner Litigation - General 2015 $1,595.00 0.70 $1,116.50
Maureen D. ECEB - Employee
Partner 1998 $2,115.00 7.40 $15,651.00
O'Brien Benefits
ECEB - Executive
Scott D. Price, P.C. Partner 1998 $2,245.00 0.50 $1,122.50
Compensation
Jay M. Ptashek, Corporate - Debt
Partner 1993 $2,245.00 1.00 $2,245.00
P.C. Finance
ECEB -
Risa Salins Partner 2002 $2,115.00 13.00 $27,495.00
Labor/Employment
Yusuf Salloum Partner Restructuring 2018 $1,595.00 32.70 $52,156.50
Corporate - Capital
Anna Schwander Partner 2002 $1,315.00 18.70 $24,590.50
Markets
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 7 of 120
Hourly
Date of Hours Billed Fees Billed
Billing Rate
Attorney Name Position Department Admissi In this In this
on In this
Application Application
Application
Paul D. Tanaka, Environment -
Partner 2003 $2,115.00 0.60 $1,269.00
P.C. Transactional
Corporate -
Steve Toth Partner 2005 $1,820.00 91.00 $165,620.00
M&A/Private Equity
Sarah Ullathorne Partner Restructuring 2004 $1,575.00 1.80 $2,835.00
Nicholas Warther Partner Taxation 2017 $1,665.00 43.60 $72,594.00
Cristina Weidner Partner Restructuring 2005 $1,665.00 5.10 $8,491.50
Spencer A.
Partner Restructuring 2013 $1,685.00 16.70 $28,139.50
Winters, P.C.
Sara B. Zablotney,
Partner Taxation 2003 $2,445.00 16.00 $39,120.00
P.C.
Totals 979.30 $1,351,219.00
The paraprofessionals of K&E who rendered professionals services in these cases during
the Fee Period are:
Position with Hourly Billing Total Billed Total
Professional Person Department
the Applicant Rate Hours Compensation
Tanzila Zomo Junior Paralegal Restructuring $355.00 4.60 $1,633.00
Julia R. Foster Paralegal Restructuring $525.00 0.90 $472.50
Totals 5.50 $2,105.50
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 8 of 120
EXHIBIT C
Summary of Actual and Necessary Expenses for the Fee Period
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 9 of 120
Expense Summary
Service Description Amount
Standard Copies or Prints $51.20
Color Copies or Prints $304.70
Local Transportation $212.99
Airfare $1,097.62
Transportation to/from airport $1,239.88
Outside Printing Services $1,771.48
Working Meals/K&E Only $0.00
Computer Database Research $1,129.00
Westlaw Research $331.15
LexisNexis Research $1,348.49
Overtime Transportation $275.54
Overtime Meals - Attorney $86.38
Computer Database Research - Soft $10.90
Total $7,859.33
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 10 of 120
EXHIBIT D
Detailed Description of Fees, Expenses, and Disbursements
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 11 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107349
Client Matter: 48520-5
In the Matter of Corporate & Governance Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 46,564.00
Total legal services rendered $ 46,564.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 12 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107349
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 5.10 1,395.00 7,114.50
Tiffani Chanroo 2.90 1,345.00 3,900.50
Jaina Desai 0.30 975.00 292.50
Luke Finn 0.70 1,345.00 941.50
Partha Kar 0.50 2,305.00 1,152.50
Sabrina Lieberman 1.60 975.00 1,560.00
Jai Mudhar 10.40 1,345.00 13,988.00
Sarah Osborne 0.90 975.00 877.50
Jay M. Ptashek, P.C. 1.00 2,245.00 2,245.00
Joshua Raphael 1.80 1,095.00 1,971.00
Steve Toth 0.70 1,820.00 1,274.00
Donatus Wang 3.80 960.00 3,648.00
Spencer A. Winters, P.C. 1.00 1,685.00 1,685.00
Sara B. Zablotney, P.C. 2.20 2,445.00 5,379.00
Ann-Kathrin Ziegler 0.50 1,070.00 535.00
TOTALS 33.40 $ 46,564.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 13 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107349
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters
Description of Legal Services
Date Name Hours Description
09/03/24 Jai Mudhar 2.00 Correspond with S. Lieberman, K&E team re
Swiss auditor (.8); review documents from
Swiss counsel (1.2).
09/04/24 Jai Mudhar 1.00 Correspond with Swiss and Dutch Local
Counsel re opt-out (.5); correspond with S.
Lieberman, K&E team re opt-out (.5).
09/04/24 Joshua Raphael 1.40 Draft special committee presentation re plan
(1.1); review, revise special committee
presentation (.2); correspond with C. Ceresa
re same (.1).
09/04/24 Steve Toth 0.70 Discuss intercompany settlement and related
matters with N. Warther, K&E team.
09/05/24 Chris Ceresa 1.60 Attend special committee conference (1.0);
draft minutes re same (.6).
09/05/24 Partha Kar 0.50 Conference with US and Swiss counsel re
auditor issues.
09/05/24 Jai Mudhar 1.20 Correspond with local counsel, S. Lieberman,
K&E team re Swiss Auditor opt-out (1.0);
review, analyze resolution from Dutch
counsel (.2).
09/05/24 Spencer A. Winters, P.C. 0.50 Attend special committee meeting.
09/05/24 Sara B. Zablotney, P.C. 2.20 Attend telephone conference re valuation (.5);
attend follow up telephone conference re
re‑allocation and intercompany (.5); attend
telephone conference re allocation (.5);
correspond with N. Warther, K&E team re
intercompany settlement (.3); review
allocation (.4).
09/06/24 Jaina Desai 0.30 Correspond with Cole Schotz, AlixPartners,
C. Ceresa, K&E team re Swiss audit
conference.
09/06/24 Jai Mudhar 1.00 Review, analyze wind-down considerations
(.7); review, analyze Swiss auditor
considerations (.3).
09/09/24 Tiffani Chanroo 1.30 Conference with S. Lieberman, K&E team,
Grant Thornton re auditor (.5); review,
analyze issues re same (.6); correspond with
S. Lieberman re same (.2).
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 14 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107349
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters
Date Name Hours Description
09/09/24 Jai Mudhar 1.50 Conference with Swiss Auditor (.5);
correspond with Swiss Counsel and Dutch
Counsel re Swiss and Dutch entities (.5);
correspond with T. Chanroo, K&E team re
Swiss auditor issues and next steps (.3);
correspond with AlixPartners re UK company
options (.2).
09/10/24 Tiffani Chanroo 1.60 Review, analyze correspondence re Swiss
auditor (1.2); correspond with S. Lieberman,
K&E team re same (.4).
09/10/24 Jai Mudhar 2.50 Conference with AlixPartners re UK entity
options (1.0); correspond with AlixPartners re
same (.8); correspond with T. Chanroo, K&E
team regarding Swiss auditor issues (.7).
09/10/24 Jay M. Ptashek, P.C. 0.50 Attend board and advisor calls.
09/11/24 Sabrina Lieberman 0.30 Correspond with J. Mudhar, T. Chanroo re
Swiss auditor resolutions.
09/11/24 Jai Mudhar 1.00 Conference with AlixPartners re UK options
(.5); correspond with AlixPartners re same
(.5).
09/11/24 Jay M. Ptashek, P.C. 0.50 Attend board and advisor calls.
09/12/24 Chris Ceresa 1.50 Conference with S. Winters and special
committee re case matters (.4); draft minutes
re same (.3); conference with J. Mudhar,
K&E team re international corporate
governance points (.8).
09/12/24 Joshua Raphael 0.40 Draft correspondence to Cole Schotz re
foreign entities (.3); correspond with C.
Ceresa re same (.1).
09/13/24 Chris Ceresa 0.40 Telephone conference with D. Wang and
K&E team re German entity corporate
governance issues.
09/13/24 Sarah Osborne 0.90 Review, revise draft correspondence to board
re audit waiver (.5); correspond with S.
Lieberman, local counsel re same (.2); draft
correspondence re same (.2).
09/13/24 Donatus Wang 0.10 Correspond with C. Ceresa, K&E team re tax
issues, novation agreement.
09/13/24 Ann-Kathrin Ziegler 0.50 Conference with D. Wang, K&E team re
German winddown and prepare for
conference.
09/16/24 Jai Mudhar 0.20 Correspond with S. Lieberman, K&E team re
Swiss opt out.
4
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 15 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107349
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters
Date Name Hours Description
09/17/24 Sabrina Lieberman 0.70 Conference with J. Mudhar re Swiss auditor
documents (.2); correspond with Company re
same (.5).
09/18/24 Chris Ceresa 0.80 Review, analyze open corporate legal issues.
09/18/24 Chris Ceresa 0.40 Telephone conference with Y. Salloum and
Company and special committee re
governance matters.
09/18/24 Sabrina Lieberman 0.30 Correspond with Company, Baker McKenzie,
J. Mudhar, K&E team re Swiss auditor.
09/19/24 Sabrina Lieberman 0.20 Correspond with Company, Baker McKenzie,
C. Ceresa, K&E team re Swiss auditor
documents.
09/23/24 Donatus Wang 3.70 Review, analyze correspondence from C.
Ceresa, K&E team, AlixPartners, Company re
intercompany issues and relevant aspects
under German law (3.0); review, revise
correspondence from C. Paus re same (.7).
09/26/24 Chris Ceresa 0.40 Draft, revise minutes re special committee
conference (.2); correspond with Company
and advisors re issues re special committee
conference (.2).
09/26/24 Luke Finn 0.30 Review, analyze Swiss entity corporate
governance documents.
09/26/24 Spencer A. Winters, P.C. 0.50 Prepare for and attend special committee
meeting.
09/28/24 Luke Finn 0.40 Review, analyze Vyaire Medical Holdings
B.V. executed board and shareholder
resolutions.
09/30/24 Sabrina Lieberman 0.10 Correspond with C. Ceresa, K&E team, Cole
Schotz re international counsel.
Total 33.40
5
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 16 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107350
Client Matter: 48520-6
In the Matter of Disclosure Statement/Plan/Confirmation
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 205,240.50
Total legal services rendered $ 205,240.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 17 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107350
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 51.10 1,395.00 71,284.50
Tiffani Chanroo 29.20 1,345.00 39,274.00
Jaina Desai 17.30 975.00 16,867.50
Michael Ehret 1.00 1,895.00 1,895.00
Luke Finn 0.40 1,345.00 538.00
Emanuel Goetz 2.50 750.00 1,875.00
Palmer Gunderson 1.20 995.00 1,194.00
David Hackel 1.50 1,095.00 1,642.50
Sabrina Lieberman 1.00 975.00 975.00
Sarah Osborne 2.10 975.00 2,047.50
Joshua Raphael 15.30 1,095.00 16,753.50
Yusuf Salloum 2.40 1,595.00 3,828.00
Seth Sanders 0.50 1,265.00 632.50
Steve Toth 1.40 1,820.00 2,548.00
Nicholas Warther 3.20 1,665.00 5,328.00
Quin Wetzel 11.40 975.00 11,115.00
Spencer A. Winters, P.C. 14.40 1,685.00 24,264.00
Sara B. Zablotney, P.C. 1.30 2,445.00 3,178.50
TOTALS 157.20 $ 205,240.50
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 18 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107350
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Description of Legal Services
Date Name Hours Description
09/02/24 Tiffani Chanroo 2.20 Review, revise disclosure statement (2.0);
correspond with Q. Wetzel, K&E team re
same (.2).
09/02/24 Sabrina Lieberman 0.10 Correspond with Q. Wetzel re confirmation
declarations.
09/02/24 Joshua Raphael 3.20 Review, revise Plan (2.9); correspond with C.
Ceresa re same (.3).
09/03/24 Chris Ceresa 7.60 Review, analyze plan and DS legal issues
(3.9); review materials and correspondence re
same (2.5); correspond with J. Raphael, K&E
team, advisors re same (1.2).
09/03/24 Chris Ceresa 0.30 Review, revise exclusivity motion.
09/03/24 Tiffani Chanroo 4.60 Review, revise disclosure statement motion,
exhibits (3.9); correspond with Q. Wetzel,
K&E team re same (.7).
09/03/24 Jaina Desai 5.80 Draft voting declaration (1.2); revise
disclosure statement (3.9); correspond with T.
Chanroo, K&E team re same (.7).
09/03/24 Jaina Desai 0.30 Review, analyze voting declaration precedent.
09/03/24 David Hackel 0.30 Analyze issues re confirmation brief (.2);
correspond with K. Chiaghana re same (.1).
09/03/24 Sabrina Lieberman 0.60 Review, revise confirmation declarations.
09/03/24 Joshua Raphael 5.40 Draft correspondence to C. Ceresa, K&E
team, Gibson Dunn re plan and disclosure
statement (.1); review, revise plan (3.0);
correspond with Cole Schotz, S. Sanders,
K&E team re same (.1); research precedent re
same (2.2).
09/03/24 Seth Sanders 0.50 Analyze issues re plan (.3); correspond with J.
Raphael, K&E team re same (.2).
09/03/24 Quin Wetzel 9.10 Research precedent disclosure statement
(2.2); review, analyze precedent releases
(1.3); correspond with T. Chanroo, C. Ceresa
re same (.6); review, revise disclosure
statement (2.2); review, revise disclosure
statement motion (1.2); review, revise
exhibits (1.6).
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 19 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107350
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Date Name Hours Description
09/03/24 Spencer A. Winters, P.C. 3.20 Review and revise draft plan (.8); review and
analyze issues re same (1.3); correspond and
telephone conferences with working group re
same (1.1).
09/04/24 Chris Ceresa 2.30 Review, analyze plan and disclosure
statement legal issues (.8); review, analyze
materials and correspondence re same (.7);
correspond with T. Chanroo, K&E team,
advisors re same (.8).
09/04/24 Chris Ceresa 0.60 Review, revise exclusivity motion.
09/04/24 Tiffani Chanroo 5.40 Conference with C. Ceresa, AlixPartners re
liquidity analysis (.5); conference with Cole
Schotz, C. Ceresa, K&E team re plan,
disclosure statement (.5); review, revise
disclosure statement motion (1.6); review,
analyze issues re same (2.8).
09/04/24 Jaina Desai 4.60 Review, analyze comments re disclosure
statement (.6); correspond with Q. Wetzel, C.
Ceresa re same (.5); revise disclosure
statement (3.5).
09/04/24 Jaina Desai 1.80 Revise disclosure statement.
09/04/24 Luke Finn 0.40 Review, analyze chapter 11 plan documents.
09/04/24 Emanuel Goetz 1.80 Review, analyze chapter 11 plan re tax issues.
09/04/24 Palmer Gunderson 1.20 Review, analyze disclosure statement and
chapter 11 plan.
09/04/24 David Hackel 1.20 Analyze issues, precedent, Company
information re confirmation brief (1.1);
correspond with K. Chiaghana, K&E team re
same (.1).
09/04/24 Sabrina Lieberman 0.30 Review, revise declaration in support of
confirmation.
09/04/24 Joshua Raphael 1.30 Conference with CS, AlixPartners, C. Ceresa,
K&E team re liquidation analysis (.4); review,
revise Plan (.1); correspond, distribute Plan to
professionals (.2); review, revise disclosure
statement (.2); coordinate, correspond with C.
Ceresa, K&E team CS re same, solicitation,
Plan (.4).
09/04/24 Steve Toth 1.40 Review, revise draft plan.
09/04/24 Quin Wetzel 2.10 Review, revise disclosure statement motion
(.8); review, revise disclosure statement
exhibits (1.2); correspond with T. Chanroo re
same (.1).
4
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 20 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107350
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Date Name Hours Description
09/04/24 Spencer A. Winters, P.C. 1.50 Review and analyze issues re plan, wind
down (.8); correspond and telephone
conferences with working group re same (.7).
09/05/24 Chris Ceresa 1.60 Review, analyze plan and DS legal issues (.7);
review precedent re same (.6); correspond
with T. Chanroo, K&E team, advisors re same
(.3).
09/05/24 Chris Ceresa 0.70 Review, revise exclusivity motion (.5);
correspond with T. Chanroo, K&E team re
issues re same (.2).
09/05/24 Tiffani Chanroo 3.60 Correspond with C. Ceresa, K&E team re
disclosure statement motion (.7); conference
with Omni team, C. Ceresa, K&E team re
solicitation (.5); review, analyze issue re same
(1.9); review, revise disclosure statement
motion (.5).
09/05/24 Jaina Desai 1.10 Revise disclosure statement motion (1.0);
correspond with T. Chanroo re same (.1).
09/05/24 Joshua Raphael 0.60 Conferences with Omni, Cole Schotz, C.
Ceresa re solicitation (.5); prepare for same
(.1).
09/05/24 Quin Wetzel 0.20 Review, revise disclosure statement motion
and exhibits (.1); correspond with T. Chanroo
re same (.1).
09/05/24 Spencer A. Winters, P.C. 0.80 Review and analyze issues re plan and
winddown.
09/06/24 Chris Ceresa 3.40 Review, analyze plan and disclosure
statement legal issues (1.2); review, analyze
materials and correspondence re same (.9);
correspond with T. Chanroo, K&E team,
advisors re same (1.3).
09/06/24 Tiffani Chanroo 0.70 Conference with C. Ceresa, K&E team,
AlixPartners, Cole Schotz re plan.
09/06/24 Michael Ehret 1.00 Review, revise draft chapter 11 plan (.8);
correspond with N. Warther, E. Goetz re same
(.2).
09/06/24 Emanuel Goetz 0.70 Review, analyze chapter 11 plan.
5
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 21 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107350
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Date Name Hours Description
09/06/24 Joshua Raphael 2.20 Review, analyze key dates and professional
fees study (.3); review, analyze precedent re
same (.5); correspond with C. Ceresa, K&E
team re same (.1); review, analyze case
milestones (.6); correspond with S. Winters,
C. Ceresa re same (.2); telephone conference
with C. Ceresa, Cole Schotz, AlixPartners re
Plan and follow up re same (.5).
09/06/24 Nicholas Warther 1.60 Review and revise tax portions of disclosure
and plan.
09/07/24 Chris Ceresa 1.30 Review, analyze plan and disclosure
statement legal issues (1.0); correspond with
T. Chanroo, K&E team, advisors re same (.3).
09/07/24 Tiffani Chanroo 1.20 Conference with C. Ceresa, K&E team re
plan, disclosure statement (.6); correspond
with Ropes, MWE, C. Ceresa re same (.6).
09/07/24 Joshua Raphael 0.30 Conference with S. Winters, C. Ceresa,
AlixPartners, Cole Schotz re plan and
disclosure statement.
09/07/24 Spencer A. Winters, P.C. 2.30 Review, analyze creditor markups to plan
(1.3); attend telephone conference with C.
Ceresa, K&E team, AlixPartners, Cole Schotz
re same (1.0).
09/09/24 Chris Ceresa 6.20 Review, revise plan (3.1); review, revise
disclosure statement (1.1); review and revise
on disclosure statement motion (1.1);
correspond with J. Raphael, K&E team, Cole
Schotz re issues re same (.9).
09/09/24 Tiffani Chanroo 1.40 Review, analyze disclosure statement timeline
(.5); correspond with Cole Schotz, Omni re
same (.4); review, analyze issues re plan (.5).
09/09/24 Joshua Raphael 0.70 Conference with C. Ceresa, K&E team, GDC
re plan (.3); correspond with C. Ceresa, K&E
team, AlixPartners, Cole Schotz re plan (.4).
09/09/24 Nicholas Warther 1.20 Review and revise tax portions of plan and
disclosure statement.
09/09/24 Spencer A. Winters, P.C. 3.20 Attend call with UCC counsel re plan and
disclosure statement (.3); attend telephone
conference with lender counsel re same (.5);
review and analyze issues re plan, disclosure
statement filing (1.3); telephone conferences
with Y. Salloum, K&E working group re
same (1.1).
6
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 22 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107350
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Date Name Hours Description
09/09/24 Sara B. Zablotney, P.C. 1.00 Review, analyze plan and disclosure
statement.
09/10/24 Chris Ceresa 3.20 Review, revise plan (1.1); review, comment
on disclosure statement (.7); review and
comment on disclosure statement motion
(1.1); correspond with J. Raphael, K&E team,
Cole Schotz re issues re same (.3).
09/10/24 Chris Ceresa 0.50 Review and revise motion to extend
exclusivity.
09/10/24 Tiffani Chanroo 2.90 Review, analyze correspondence from C.
Ceresa, K&E team re plan.
09/10/24 Joshua Raphael 0.60 Correspond with C. Ceresa re plan opt out
(.2); review, revise plan (.3); review, analyze
tax comments to plan (.1).
09/10/24 Nicholas Warther 0.40 Review and revise plan.
09/10/24 Spencer A. Winters, P.C. 1.20 Review and analyze issues re plan filing (.6);
correspond and telephone conferences with C.
Ceresa, K&E team re same (.6).
09/10/24 Sara B. Zablotney, P.C. 0.20 Conference with C. Ceresa, K&E team re plan
language.
09/11/24 Chris Ceresa 2.40 Review, revise Plan (1.0); review disclosure
statement and DS motion (.4); correspond
with S. Winters, K&E team, Cole Schotz re
issues re Plan, DS, and DS Motion (.7);
correspond with Cole Schotz re filing the
same (.3).
09/11/24 Joshua Raphael 0.30 Review, revise Plan (.2); correspond with C.
Ceresa, T. Chanroo re same (.1).
09/11/24 Spencer A. Winters, P.C. 1.30 Attend standing telephone conferences with
Company, Company advisors (1.0); review
and analyze issues re filing of plan,
Disclosure Statement (.3).
09/12/24 Chris Ceresa 0.70 Review and analyze plan legal issues (.5);
review correspondence with Cole Schotz re
same (.2).
09/12/24 Joshua Raphael 0.60 Review, analyze plan, disclosure statement,
disclosure statement motion (.4); correspond
with C. Ceresa, MWE re same (.2).
09/12/24 Sara B. Zablotney, P.C. 0.10 Attend telephone conference with S. Winters
re plan.
09/16/24 Joshua Raphael 0.10 Correspond with C. Ceresa re Plan.
7
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 23 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107350
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Date Name Hours Description
09/17/24 Chris Ceresa 7.50 Review, analyze legal issues re Plan and
solicitation (3.9); telephone conferences with
Y. Salloum, K&E team, Cole Schotz, counsel
re issues re same (1.9); correspond with Y.
Salloum, K&E team, Cole Schotz, counsel re
issues (1.7).
09/18/24 Chris Ceresa 0.20 Correspond with Cole Schotz re plan and
solicitation issues.
09/18/24 Tiffani Chanroo 7.20 Review, analyze plan (3.9); review, revise
same (3.3).
09/19/24 Chris Ceresa 7.50 Review, analyze legal issues re Plan and
solicitation (3.9); telephone conferences with
Y. Salloum, K&E team, Cole Schotz, counsel
re issues re same (1.9); correspond with Y.
Salloum, K&E team, Cole Schotz, counsel re
issues (1.7).
09/23/24 Chris Ceresa 2.80 Review, analyze plan legal issues (1.4);
review and revise disclosure statement and
plan (1.0); correspond with Cole Schotz re
same (.4).
09/23/24 Jaina Desai 2.00 Review, analyze plan (.8); review, analyze
Plan precedent (.5); draft responses to U.S.
Trustee comments re disclosure statement
(.3); correspond with S. Osborne re same (.2);
review, analyze correspondence from C.
Ceresa, K&E team re same (.2).
09/23/24 Sarah Osborne 2.10 Research precedent re U.S. Trustee objections
to plan and disclosure statement (1.7); review,
revise response summary re same (.4).
09/24/24 Chris Ceresa 0.30 Review, analyze plan legal issues (.1); review
and comment on disclosure statement and
plan (.1); correspond with Cole Schotz team
re same (.1).
09/24/24 Jaina Desai 1.70 Review, analyze plan, disclosure statement re
issues (1.4); draft responses re U.S. Trustee
questions re same (.3).
09/26/24 Chris Ceresa 1.40 Review, analyze plan legal issues (.8); review
and revise disclosure statement and plan (.4);
correspond with Cole Schotz team re same
(.2).
09/26/24 Yusuf Salloum 2.40 Prepare for disclosure statement hearing.
09/26/24 Spencer A. Winters, P.C. 0.40 Review and analyze issues re confirmation
status, open issues.
8
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 24 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107350
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation
Date Name Hours Description
09/28/24 Chris Ceresa 0.60 Review, analyze plan legal issues (.3); review
and revise disclosure statement and plan (.2);
correspond with Cole Schotz team re same
(.1).
09/30/24 Spencer A. Winters, P.C. 0.50 Review and analyze issues re disclosure
statement hearing, case status.
Total 157.20
9
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 25 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107351
Client Matter: 48520-7
In the Matter of DIP Financing and Cash Collateral
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 3,815.00
Total legal services rendered $ 3,815.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 26 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107351
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 1.20 1,395.00 1,674.00
Joshua Raphael 0.80 1,095.00 876.00
Adrian Salmen 1.00 1,265.00 1,265.00
TOTALS 3.00 $ 3,815.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 27 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107351
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral
Description of Legal Services
Date Name Hours Description
09/04/24 Adrian Salmen 0.40 Correspond with C. Ceresa, K&E team,
AlixPartners re professional fees.
09/05/24 Chris Ceresa 0.50 Review, analyze legal issues re DIP financing
(.4); correspond with Company advisors re
same (.1).
09/05/24 Joshua Raphael 0.20 Correspond with DIP agent, C. Ceresa, K&E
team, AlixPartners re DIP withdrawal request
(.1); review, analyze DIP milestones (.1).
09/07/24 Joshua Raphael 0.10 Draft DIP milestone extension waiver.
09/11/24 Adrian Salmen 0.20 Correspond with C. Ceresa, K&E team re
professional fees.
09/13/24 Chris Ceresa 0.30 Review proposed DIP reporting (.2);
correspond with J. Raphael re same (.1).
09/13/24 Joshua Raphael 0.30 Conference with C. Ceresa, AlixPartners re
updated budget (.1); review, analyze order re
same (.1); draft DIP variance report (.1).
09/16/24 Joshua Raphael 0.10 Review, analyze DIP.
09/18/24 Adrian Salmen 0.20 Correspond with C. Ceresa, K&E team re
professional fees.
09/19/24 Chris Ceresa 0.40 Review, analyze DIP reporting (.3);
correspond with J. Raphael re same (.1).
09/19/24 Joshua Raphael 0.10 Prepare DIP draw requests.
09/25/24 Adrian Salmen 0.20 Correspond with C. Ceresa, AlixPartners re
professional fees.
Total 3.00
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 28 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107352
Client Matter: 48520-10
In the Matter of Asset Sales/Section 363 Issues: Use, Sale & Disposition of Property
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 679,253.50
Total legal services rendered $ 679,253.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 29 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Summary of Hours Billed
Name Hours Rate Amount
Hendrik Braun 3.50 1,145.00 4,007.50
Chris Ceresa 10.40 1,395.00 14,508.00
Tiffani Chanroo 3.50 1,345.00 4,707.50
Erica D. Clark 0.20 1,595.00 319.00
Bernadette Coppola 3.00 1,575.00 4,725.00
Hannah Crawford 0.30 1,595.00 478.50
Erin Davey 5.80 975.00 5,655.00
Sion Davies 0.60 1,575.00 945.00
Tabitha J. De Paulo 2.60 1,435.00 3,731.00
Anthony M. Del Rio 1.40 1,595.00 2,233.00
Jaina Desai 4.30 975.00 4,192.50
Michael Ehret 1.20 1,895.00 2,274.00
Luke Finn 99.30 1,345.00 133,558.50
Justin M. Garfinkle 2.40 1,095.00 2,628.00
Emanuel Goetz 1.00 750.00 750.00
Palmer Gunderson 24.10 995.00 23,979.50
David Hackel 1.10 1,095.00 1,204.50
Kate Hardey 9.10 1,995.00 18,154.50
Olivia Kaufmann 0.20 1,095.00 219.00
Sabrina Lieberman 0.20 975.00 195.00
Ruan J. Meintjes 6.70 1,095.00 7,336.50
Jai Mudhar 1.50 1,345.00 2,017.50
Trent Nachbar 15.80 1,265.00 19,987.00
Maureen D. O'Brien 1.50 2,115.00 3,172.50
Dan O'Connor 16.90 1,345.00 22,730.50
Carolin Paus 40.20 750.00 30,150.00
Joshua Raphael 40.20 1,095.00 44,019.00
Yusuf Salloum 29.30 1,595.00 46,733.50
Anna Schwander 18.70 1,315.00 24,590.50
Scottie Shermetaro 10.40 1,575.00 16,380.00
Paul D. Tanaka, P.C. 0.60 2,115.00 1,269.00
Steve Toth 84.30 1,820.00 153,426.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 30 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Name Hours Rate Amount
Sarah Ullathorne 1.80 1,575.00 2,835.00
Paul Vasiloff 3.50 1,345.00 4,707.50
Donatus Wang 10.60 960.00 10,176.00
Nicholas Warther 17.40 1,665.00 28,971.00
Cristina Weidner 5.10 1,665.00 8,491.50
Sara B. Zablotney, P.C. 6.10 2,445.00 14,914.50
Ann-Kathrin Ziegler 8.30 1,070.00 8,881.00
TOTALS 493.10 $ 679,253.50
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 31 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Description of Legal Services
Date Name Hours Description
08/16/24 Joshua Raphael 5.00 Conference with E. Clark, K&E team re sale
process (.6) review, revise sale order and
correspond with E. Clark, K&E team re same
(.2). review, revise declarations in support of
sale orders (2.5); correspond with T. de Paolo,
AlixPartners re same (.1); conference with
UCC, S. Winters, K&E team re sale (.1);
correspond with C. Ceresa re draft APAs (.2);
correspondence with E. Clark, K&E team re
sale order language (.2); review, analyze
comments to sale order and correspond re
same (.4); research sale order language (.4);
correspond with PJT re auction (.1);
correspond with parties in interest re sale
order objections (.2).
08/19/24 Joshua Raphael 2.60 Review, revise sale declarations (.4);
correspond with C. Ceresa, K&E team re sale
orders, declarations, objections, related items
(.4); review, analyze Hartford objection to
sale (.4); correspondence with Hartford re
same (.1); correspond with L. Finn re sale
objection (.1); research, draft sale order
language (.4); review, revise successful bidder
notice (.3); correspond with C. Ceresa, K&E
team, Omni re noticing (.1); correspond with
Covington re sale objection (.2); conference
with E. Clark, K&E team re sale workstream
(.2).
4
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 32 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
08/21/24 Joshua Raphael 6.40 Conference with E. Clark, K&E team re sale
(.6); conference with Cole Schotz, K&E team
re sale hearing (.4); correspond with C.
Ceresa, K&E team re sale orders,
declarations, objections (.5); review, analyze
sale orders (.2); revise sale declarations (.3)
finalize declarations and correspond with
advisors, C. Ceresa, K&E team re same (.2);
review, analyze APAs (.2); review, revise sale
hearing agenda (.7); correspond with E. Clark,
K&E team re same (.1); draft sale hearing
presentation (1.4); review, revise presentation
(1.0); correspond with C. Ceresa re same (.1);
correspond, conference with Omni, C. Ceresa
K&E team re service of sale hearing notice
(.6); correspond with S. Winters, C. Ceresa re
sale hearing presentation (.1).
08/22/24 Joshua Raphael 1.00 Conference with counsel to Hartford (.1);
correspond, conference with Omni, C. Ceresa,
K&E team re service (.1); conference with
AlixPartners, T. Paolo, K&E team re sale
hearing presentation (.8).
08/23/24 Joshua Raphael 4.50 Telephone conference with T. Chanroo, K&E
team re sale workstream (.4); review, revise
sale orders (2.4); correspond with T. Chanroo
re same (.1); review, analyze summary re
sales (.2); correspond with S. Osborne re
same (.2); review, analyze correspondence re
sale, sale objections (.2); revise, sale
objections summary chart (1.0).
08/26/24 Joshua Raphael 4.30 Review, revise sale orders and sale hearing
presentation (1.4); correspond with E. Clark,
K&E team re same (.3); attend status
conference re sale hearing (.4); research re
sale order proceeds, holdback (.7); correspond
with C. Ceresa, K&E team re same, sale
order, RSA, sale Orders (1.1); conference
with Company, D. O'Connor, A&M re surety
bonds (.4).
5
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 33 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
08/28/24 Joshua Raphael 9.60 Review, revise sale hearing presentation and
correspond with AlixPartners re same (.7);
draft sale reply (3.9); correspond with C.
Ceresa re same (.1); research re same (.8);
continue drafting reply (.5); review, revise
plan (.1); conference with T. Paulo, K&E
team, AlixPartners re holdback schedule
(1.0); research re sale (.1); draft sale hearing
presentation (.9); continue drafting reply and
research re same (1.5).
08/30/24 Joshua Raphael 4.30 Conferences with AlixPartners, T Paulo, K&E
team re sale hearing (.9); review, revise sale
hearing presentation (.3); review, analyze
timeline re sale hearing presentation (.4);
attend sale hearing and prepare for same (2.7).
09/01/24 Luke Finn 1.40 Review, analyze day-of-signing
communication and administrative matters for
Asset Purchase Agreement.
09/02/24 Sion Davies 0.20 Correspond with German counsel re Germany
FDI filing.
09/02/24 Palmer Gunderson 0.40 Correspond with Company re purchase price
allocation principles.
09/03/24 Chris Ceresa 1.20 Review, analyze sale-related legal issues (.8);
correspond with Y. Salloum, K&E team,
Company re issues re same (.4).
09/03/24 Bernadette Coppola 0.30 Correspond with Company, S. Toth, and K&E
team re entity merger (.1); correspond with
buyer’s counsel, S. Toth, and K&E team re
license terms (.2).
09/03/24 Tabitha J. De Paulo 0.60 Conference with AlixPartners team re
follow‑up requests from BRG re sale.
09/03/24 Anthony M. Del Rio 0.30 Review, analyze regulatory filings.
09/03/24 Jaina Desai 1.00 Conference with C. Ceresa re cure objections
(.1); correspond with T. Chanroo, J. Raphael
re same (.1); correspond with AlixPartners, K.
Chiaghana re same (.2); review, analyze
correspondence re same (.3); review, analyze
objection tracker (.2); correspond with S.
Lieberman re sale workstream (.1).
6
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 34 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/03/24 Luke Finn 4.40 Review, analyze post-signing communication
and administrative matters for asset purchase
agreement (1.5); review, revise Closing
checklist (.8); review, revise Schedule
attachments (1.2); correspond with Company
and Cooley re various open sale issues (.9).
09/03/24 Justin M. Garfinkle 0.50 Draft list of entities selling intellectual
property.
09/03/24 Emanuel Goetz 1.00 Draft correspondence to German counsel re
German real estate transfer tax implications in
connection with the restructuring transactions.
09/03/24 David Hackel 0.70 Review, analyze issues re sales and sale
hearing (.3); draft, revise analysis re same
(.3); correspond with C. Ceresa, K&E team re
same (.1).
09/03/24 Olivia Kaufmann 0.20 Conference with K. Hardey and R. Meintjes
re license update.
09/03/24 Ruan J. Meintjes 0.30 Correspond with O. Kaufmann, K&E team re
California manufacturer license filings.
09/03/24 Dan O'Connor 2.40 Telephone conference with S. Winters, S.
Toth and C. Ceresa re APA and UCC matters
(.3); review and revise disclosure schedules
(.7); correspond with various parties re APA
and disclosure schedule matters (.6);
correspond with MWE re APA matters (.4);
correspond with Gibson Dunn re APA matters
(.4).
09/03/24 Scottie Shermetaro 0.70 Review and revise IP disclosure schedules.
09/03/24 Paul D. Tanaka, P.C. 0.60 Review and analyze asset purchase agreement
(.4); correspond with L. Finn, K&E team re
same (.2).
09/03/24 Steve Toth 0.90 Discuss update with S. Winters and D.
O’Connor, K&E team (.3); analyze APAs re
closing preparation (.6).
09/04/24 Chris Ceresa 2.60 Review, analyze sale-related legal issues
(2.1); correspond with Y. Salloum, K&E
team, Company, advisors re same (.5).
09/04/24 Tiffani Chanroo 0.50 Conference with C. Ceresa, Cole Schotz,
AlixPartners, Company re cure objections.
7
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 35 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/04/24 Tiffani Chanroo 2.60 Correspond with counterparties re cures (.3);
review, revise cure objection summary (1.3);
correspond with Cole Schotz team re same
(.2); review, analyze issue re same (.8).
09/04/24 Erica D. Clark 0.20 Analyze cure issues and correspond with C.
Ceresa, K&E team re same.
09/04/24 Tabitha J. De Paulo 2.00 Review, analyze sale motion and related
declarations.
09/04/24 Luke Finn 2.50 Correspond with MWE re final signing sets
(.4); conference with J. Raphael re tax
documentation (.6); review, analyze
correspondence from Cooley re international
issues (.8); review, analyze final RDx Asset
Purchase Agreement (.7).
09/04/24 Justin M. Garfinkle 0.30 Review, analyze IP transfer.
09/04/24 Palmer Gunderson 4.20 Telephone conference with N. Warther, K&E
team re pre‑closing tax planning (.8); revise
purchase price allocations for sale
transactions (1.5); correspond with N.
Warther, K&E team re pre‑closing
restructuring transactions (.6); correspond
with N. Warther re purchase price allocations
for sale transactions (1.3).
09/04/24 Palmer Gunderson 0.40 Review Seller comments on purchase price
allocation for sale transaction.
09/04/24 Joshua Raphael 0.40 Conference with C. Ceresa, K&E team, CS,
AlixPartners, Company re cure reconciliation.
09/04/24 Scottie Shermetaro 0.40 Review and revise IP disclosure schedules.
09/04/24 Steve Toth 1.10 Respond to correspondence from Company,
N. Warther, K&E re internal merger
considerations (.3); analyze and respond to
correspondence from Company and
AlixPartners re APA matters (.4); correspond
with Y. Salloum, K&E team re same (.3);
conference with Crowell re same (.1).
09/04/24 Nicholas Warther 4.00 Telephone conference with Company re
purchase price allocation and closing matters
(1.0); review and analyze same (1.2);
telephone conference with S. Zablotney, K&E
team re documentation for closing (1.0);
review and analyze merger and
documentation (.8).
8
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 36 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/04/24 Sara B. Zablotney, P.C. 1.00 Attend telephone conference with N. Warther,
K&E team re closing matters (.5); attend
follow up telephone conference with N.
Warther re allocation (.5).
09/05/24 Chris Ceresa 0.20 Review, analyze sale-related legal issues (.1);
correspond with J. Desai, K&E team re same
(.1).
09/05/24 Tiffani Chanroo 0.40 Correspond with counterparty re cure issues.
09/05/24 Jaina Desai 0.80 Telephone conference with C. Ceresa re sale
workstream transition to Cole Schotz (.2);
correspond with C. Ceresa re same (.1);
correspond with T. Chanroo re same (.1);
correspond with cure parties, T. Chanroo,
K&E team re cure objections (.4).
09/05/24 Luke Finn 1.30 Revise draft of Interim Operating Covenant
memorandum.
09/05/24 Justin M. Garfinkle 0.30 Review, analyze IP transfer.
09/05/24 David Hackel 0.40 Analyze issues re sales.
09/05/24 Dan O'Connor 0.80 Telephone conference with Crowell, Deloitte
S. Zablotney, K&E team re allocation
schedule (.4); correspond with S. Zablotney,
K&E team and Company re same (.4).
09/05/24 Scottie Shermetaro 0.30 Correspond with Company re IP Disclosure
Schedules.
09/05/24 Steve Toth 1.80 Participate in management update
teleconference with Company, S. Winters,
PJT, AlixPartners re sale issues (.3);
correspond with Y. Salloum, K&E team re
APA and closing matters (.6); analyze and
update attorney notes and list re closing
preparation and issues (.9).
09/05/24 Donatus Wang 0.40 Review and analyze update on sales processes
(.2); conference with C. Weidner, K&E team
re same (.2).
09/05/24 Nicholas Warther 0.50 Telephone conference with Deloitte and
Crowell re APA.
09/05/24 Cristina Weidner 0.50 Conference with D. Wang, K&E team re sales
process.
9
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 37 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/06/24 Jaina Desai 1.40 Correspond with D. O’Connor re sale
workstream (.1); correspond with T. Chanroo,
C. Ceresa re correspondence from cure parties
(.3); draft correspondence to CS re sale
workstream transition (.3); review, analyze
objection summary re cure objection (.4);
correspond with AlixPartners, Cole Schotz re
same (.3).
09/06/24 Luke Finn 0.80 Review, revise closing checklist.
09/06/24 Kate Hardey 0.50 Review, analyze buyer liability (.3);
conference with A. Del Rio re same (.2).
09/06/24 Trent Nachbar 4.50 Draft, revise closing checklist (3.9); review,
analyze same (.6).
09/06/24 Dan O'Connor 0.80 Telephone conference with Crowell, Deloitte
and tax team re allocation schedule (.4);
correspond with N. Warther, K&E tax
team, Company re same (.4).
09/06/24 Anna Schwander 0.80 Review, analyze FDI filing (.4); review,
analyze correspondence re annexes (.4).
09/06/24 Nicholas Warther 0.40 Correspond with Company re purchase price
allocation.
09/06/24 Sara B. Zablotney, P.C. 0.20 Correspond with N. Warther, K&E team re
APA.
09/09/24 Chris Ceresa 0.30 Review, analyze legal issues re international
entities in context of sales.
09/09/24 Bernadette Coppola 0.20 Correspond with Company, S. Toth, K&E
team re sales of intellectual property.
09/09/24 Sion Davies 0.20 Correspond with German counsel re German
FDI.
09/09/24 Jaina Desai 0.50 Review, analyze correspondence from S. Toth
re sale workstream (.3); correspond with T.
Chanroo, K&E team re same (.2).
09/09/24 Luke Finn 1.60 Revise draft of Interim Operating Procedures
memorandum (1.2); conference with
Company re same (.4).
09/09/24 Justin M. Garfinkle 0.50 Review, analyze IP transfers.
09/09/24 Anna Schwander 1.80 Prepare German FDI filing with bidder
counsel.
09/09/24 Scottie Shermetaro 0.10 Review and revise TSA schedules.
09/09/24 Steve Toth 0.60 Analyze Company correspondence re
diligence, TSA, IP and Brazil.
10
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 38 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/10/24 Sion Davies 0.20 Correspond with German counsel re filing
preparation.
09/10/24 Jaina Desai 0.60 Review, analyze cure objections (.2);
correspond with AlixPartners, Cole Schotz re
same (.4).
09/10/24 Michael Ehret 0.30 Review, analyze correspondence from N.
Warther re purchase price allocation, sales
model post close.
09/10/24 Luke Finn 1.70 Revise sale‑related memorandum to clients
(1.2); review, analyze correspondence with
AlixPartners team re final Asset Purchase
Agreements (.5).
09/10/24 Palmer Gunderson 0.70 Correspond with Company re purchase price
allocation (.5); correspond with N. Warther,
S. Zablotney, Company re sale structure and
timing (.2).
09/10/24 Dan O'Connor 1.60 Correspond with S. Toth, K&E team and
equityholder re FDI filing matters (.6);
correspond with A. Schwander re Germany
FDI filing (1.0).
09/10/24 Anna Schwander 1.30 Prepare German FDI filing.
09/10/24 Steve Toth 2.20 Analyze correspondence re foreign assets and
antitrust data (.2); revise interim operating
covenant memorandum (2.0).
09/10/24 Donatus Wang 0.20 Correspond with C. Ceresa, K&E team re sale
processes.
09/10/24 Nicholas Warther 1.20 Review and analyze purchase price allocation
for buyer.
09/11/24 Bernadette Coppola 0.20 Correspond with advisors re transition
services agreement schedules.
09/11/24 Anthony M. Del Rio 0.30 Review and analysis of inquiry from T.
McDaniel re post-emergence liabilities.
09/11/24 Luke Finn 2.80 Draft Closing Checklist for Asset
Purchase (1.3); review,
analyze correspondence from Company
regarding Interim Operating Covenants (.7);
revise internal administrative matters for
purchase agreement (.8).
11
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 39 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/11/24 Palmer Gunderson 1.20 Prepare notes for conference with Company
re purchase price allocation (.3); telephone
conference with Company, N. Warther, K&E
team re purchase price allocation and sale
timing (.9).
09/11/24 Maureen D. O'Brien 1.00 Attend winddown conference with S. Toth,
K&E team (.5); review, analyze guidance and
plan documents (.5).
09/11/24 Dan O'Connor 1.00 Telephone conference with Company, S.
Toth, K&E team re purchase price allocation
and transaction matters.
09/11/24 Anna Schwander 0.80 Correspond with buyer re due diligence (.4);
revise APA (.4).
09/11/24 Scottie Shermetaro 0.10 Correspond with IT consultants re service
level agreements in the TSA.
09/11/24 Steve Toth 2.10 Analyze attorney notes re closing and
international matters (.4); conference with
Company and P. Gunderson, K&E team re
ERP and TSA matters (1.0); participate in
update teleconference with Company and
advisors (.1); discuss closing matters with D.
O’Connor (.2); review, revise attorney notes
re closing matters and related correspondence
(.4).
09/11/24 Paul Vasiloff 3.50 Research re employment issues re sale
transactions.
09/11/24 Nicholas Warther 3.20 Telephone conference with Company, P.
Gunderson, K&E team re purchase price
allocation and sale (1.2); review and analyze
question re US tax modeling (1.6); correspond
with P. Gunderson, K&E team re structuring
(.4).
09/11/24 Sara B. Zablotney, P.C. 1.40 Attend telephone conference with N. Warther,
K&E team re purchase price allocation (1.0);
reinvest comment on summary (.4).
09/12/24 Bernadette Coppola 0.80 Conference with buyer’s counsel and
AlixPartners re transition services agreement
schedules (.4); conference with S. Toth and
AlixPartners re same (.2); review, analyze
comments to transition services agreement
schedules (.1); correspond with S. Toth re
same (.1).
12
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 40 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/12/24 Erin Davey 1.80 Research employment questions in
connection with transactions.
09/12/24 Luke Finn 3.20 Correspond with Company, Cooley re
contract (1.5); review, analyze German entity
matters (1.7).
09/12/24 Justin M. Garfinkle 0.60 Review, analyze issues re IP transfers.
09/12/24 Palmer Gunderson 1.30 Review, analyze Brazil sale offer letter and
(.4); review, analyze structure slides for
restructuring and sales transaction (.4);
correspond with Company re structure slides
and Brazil sale (.5).
09/12/24 Dan O'Connor 2.60 Prepare side letter re asset storage and lease
termination.
09/12/24 Joshua Raphael 0.40 Telephone conference with Cole Schotz, C.
Ceresa, K&E team re UK, international
considerations re sale.
09/12/24 Joshua Raphael 0.30 Revise bid summaries re foreign entities (.2);
correspond with L. Finn, K&E team re
transactions, foreign entities (.1).
09/12/24 Anna Schwander 4.30 Correspond with buyer counsel re German
FDI and due diligence (2.3); review, draft,
and amend draft Annexes (2.0).
09/12/24 Steve Toth 2.60 Participate in weekly advisor update
telephone conference (.5); analyze lease exit
(.2); analyze closing matters (.3); discuss TSA
matters with B. Coppola and AlixPartners
(.3); review, revise equipment letter (.7);
analyze Brazil LOI (.3) discuss business lines
with AlixPartners (.2); prepare related
correspondence (.1).
09/12/24 Nicholas Warther 0.10 Correspond with S. Zablotney, K&E team re
APA.
09/13/24 Chris Ceresa 0.50 Review, analyze legal issues re international
entities in context of sales.
09/13/24 Chris Ceresa 0.70 Review, analyze issues re lease treatment in
sale.
13
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 41 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/13/24 Luke Finn 2.40 Attend Closing Request conference (.8);
correspond with S. Toth re Closing checklist
(.5); review, analyze correspondence re
Brazilian subsidiary questions and
information sharing (.3); review, analyze
German counsel correspondence re German
entities and German‑held assets (.8).
09/13/24 Palmer Gunderson 2.70 Review and prepare tax comments for
structure slides for restructuring and sale
transactions.
09/13/24 Dan O'Connor 5.80 Review and revise Germany FDI response
summary (1.3); review and revise ultimate
beneficial owner structure summary re same
(1.0); telephone conference with Company,
AlixPartners, S. Toth and re closing matters
(.5); telephone conference with AlixPartners
and S. Toth re lease matters (.4); prepare
closing checklist for APA (2.6).
09/13/24 Carolin Paus 0.50 Conference with J. Raphael re closing.
09/13/24 Joshua Raphael 1.30 Review, analyze disclosure schedules and
correspond with Cole Schotz, C. Paus, K&E
team re foreign assets, entities (.7); telephone
conference with Cole Schotz, C. Ceresa, K&E
team re international considerations, German
entities (.5); correspond with D. Wang, K&E
team re transaction steps (.1).
09/13/24 Anna Schwander 6.80 Finalize of German FDI application (3.9);
finalize German FDI annexes (2.1);
correspond with buyer counsel re same (.8).
09/13/24 Scottie Shermetaro 0.80 Review and revise TSA Schedules.
09/13/24 Steve Toth 1.10 Discuss closing timing with Company,
AlixPartners, D. O’Connor, K&E team (.5);
analyze and respond to correspondence re
asset lines and related issues (.3); analyze
correspondence re diligence and closing
matters (.3).
09/14/24 Luke Finn 0.80 Review, analyze Side Letter re Irvine Asset
Storage correspondence (.3); review and
update Closing checklist (.5).
09/14/24 Maureen D. O'Brien 0.50 Review, analyze safe harbor research.
14
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 42 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/15/24 Luke Finn 1.10 Review, analyze correspondence from BDO
(.3); review, analyze settlement issue (.4);
review, analyze to Side Letter re Irvine Asset
Storage (.4).
09/15/24 Steve Toth 1.10 Analyze intercompany settlement deck (.5);
analyze diligence and closing matters (.6).
09/16/24 Erin Davey 1.00 Research employment‑related issue re sales.
09/16/24 Luke Finn 5.70 Review assets sale process (.3); attend
conference re product (1.4); review legacy
assets questions from buyer (.4); prepare
drafts and send updates and requests to J.
Mudhar, K&E team (.8); revise Closing
Checklist (1.1); correspond with Company re
lease agreement (.8); attend APA Transaction
Planning conference (.9).
09/16/24 Palmer Gunderson 1.00 Telephone conference with Company, N.
Warther, K&E team re sale transaction
planning steps (.7); telephone conference with
Company and purchaser re purchase price
allocation and sale timer (.3).
09/16/24 Palmer Gunderson 1.20 Update structure slides for sale transactions
(.6); correspond with accounting team re pre-
closing restructuring structure slides (.6).
09/16/24 Kate Hardey 2.20 Review inventory products and related
questions re FDA compliance matters for
Remaining entities (1.7); conference with R.
Meintjes re same (.5).
09/16/24 Ruan J. Meintjes 2.50 Research and analyze post-closing regulatory
obligations (1.9); draft summary of findings
(.3); conference with K Hardey re the same
(.3).
09/16/24 Carolin Paus 4.50 Review, analyze asset purchase agreements.
09/16/24 Yusuf Salloum 1.00 Analyze issues re sale transactions.
09/16/24 Anna Schwander 0.80 Review, analyze FDI filing.
15
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 43 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/16/24 Steve Toth 5.00 Discuss international closing matters with
Company and AlixPartners (.7); participate in
executive steering committee teleconference
with Company and advisors (.3); participate
in lender advisor update teleconference with
lender advisors, Company, advisors (.1);
participate in advisors update teleconference
with AlixPartners, PJT, Y. Salloum, K&E
team (.2); analyze Brazil LOI (.3); conference
with Company and AlixPartners re same (.7);
analyze and revise closing checklist (1.8);
revise Brazil LOI (.9).
09/16/24 Nicholas Warther 1.50 Telephone conference with Company re APA
workstreams (.5); telephone conference with
buyer re same (1.0).
09/16/24 Sara B. Zablotney, P.C. 0.50 Attend telephone conference with Company,
S. Toth and K&E team re APA.
09/16/24 Sara B. Zablotney, P.C. 0.50 Attend telephone conference with Company,
S. Toth and K&E team re APA.
09/17/24 Chris Ceresa 0.80 Review, analyze open sale closing issues.
09/17/24 Bernadette Coppola 0.20 Correspond with Company and M. King, S.
Toth, K&E team re intellectual property
schedule (.1); correspond with M. King and
K&E team re transition services agreement
schedules (.1).
09/17/24 Hannah Crawford 0.30 Correspond with J. Mudhar re ex-US asset
and equity transfer process.
09/17/24 Anthony M. Del Rio 0.40 Review, analyze regulatory and quality
transition requirements for non-acquired
products.
09/17/24 Michael Ehret 0.10 Correspond with Deloitte, buyer re
transaction.
09/17/24 Luke Finn 5.50 Correspond with foreign local counsel re sale
(2.7); review, analyze deal interim balance
sheet (.5); review, analyze foreign
correspondence re bankruptcy‑specific issue
re sale (1.5); review, analyze LOI (.8).
09/17/24 Justin M. Garfinkle 0.20 Review, analyze registered IP schedule.
09/17/24 Palmer Gunderson 0.10 Correspond with purchasers re company draft
disclosure.
09/17/24 Palmer Gunderson 0.30 Correspond with Company and corporate
teams re Brazil Sale.
16
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 44 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/17/24 Kate Hardey 3.40 Participate in telephone conference with
Company re FDA product transition matters
(1.0); review, analyze FDA considerations re
product discontinuation (2.1); conference with
R. Meintjes re same (.3).
09/17/24 Ruan J. Meintjes 2.30 Conference with Company re product closure
(1.0); conduct FDA research re ongoing
obligations (1.0); conference with K. Hardey
re the same (.3).
09/17/24 Jai Mudhar 1.50 Correspond with L. Finn re transaction (.5);
correspond with local counsels re transaction
(1.0).
09/17/24 Dan O'Connor 0.50 Correspond with L. Finn re local counsel
matters.
09/17/24 Carolin Paus 1.20 Conference with S. Toth, K&E team re sale.
09/17/24 Carolin Paus 0.50 Draft issues list re sale.
09/17/24 Scottie Shermetaro 0.30 Review and revise TSA Schedules.
09/17/24 Steve Toth 4.80 Participate in steering committee telephone
conference with Company and AlixPartners
(.6); analyze related correspondence (.2);
prepare intercompany novation agreement
(3.0); discuss Brazil LOI with Company and
AlixPartners (.5); revise LOI (.2); analyze
assumed liabilities (.3).
09/17/24 Sarah Ullathorne 1.00 Correspond with Company advisors re
questions on asset and equity transfer.
09/17/24 Donatus Wang 2.00 Analyze structuring of asset sale transactions
and debt assumption contemplated in APA,
(1.2); draft questions on structural aspects
(.5); discuss same with C. Paus and A. Ziegler
(.3).
09/17/24 Ann-Kathrin Ziegler 1.00 Conference with D. Wang, K&E team re
German entities sales process documents and
associated workstreams (.7); review, analyze
correspondence re same (.3).
09/18/24 Chris Ceresa 0.30 Telephone conference with S. Toth, K&E
team, advisors re sale legal issues.
09/18/24 Bernadette Coppola 0.10 Correspond with Company, L. Finn, K&E
team re intellectual property schedules.
17
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 45 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/18/24 Luke Finn 6.50 Review, analyze correspondence with
Singaporean counsel re asset purchase (.8);
review, analyze correspondence with Turkish
and UAE, counsel (.2); review, analyze
correspondence with Dutch counsel re asset
and equity purchase (1.4); draft update on
Italian asset agreement (.2); review, analyze
correspondence with Cooley re imt medical
(.5); review, analyze correspondence with
Company re IP (.3); attend conference with
prospective buyer (1.0); revise Closing
checklist (.6) review, analyze McDermott
Will & Emery correspondence (.3);
correspond with Cooley re closing checklist
(.4); correspond with Brazilian counsel re
asset purchase (.8).
09/18/24 Palmer Gunderson 0.40 Review accounting team pre-closing
restructuring slides.
09/18/24 Kate Hardey 1.40 Conference with S. Toth re FDA post-market
product considerations (.4); review and revise
FDA notice re same (1.0).
09/18/24 Ruan J. Meintjes 0.60 Conference with S. Toth re closing deadline
and regulatory considerations (.3); coordinate
with K. Hardey re follow-up research (.3).
09/18/24 Dan O'Connor 1.40 Correspondence with Company and A.
Schwander re FDI filings (.5); review and
revise same (.5); telephone conference with
A. Terranova and A. Schwander re FDI
filings (.4).
09/18/24 Yusuf Salloum 2.20 Review, analyze issues re sale closing.
09/18/24 Anna Schwander 1.30 Review, analyze correspondence re FDI.
09/18/24 Scottie Shermetaro 0.60 Review, analyze APA obligations re IP.
18
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 46 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/18/24 Steve Toth 3.30 Analyze international closing matters (.2);
discuss regulatory considerations with S.
Winters, K&E team (.1); analyze German
counsel correspondence re IP, Germany and
lease matters (.4); analyze correspondence re
Brazil and other intercompany matters (.3);
discuss LOI with bidder, bidder advisor,
working group (1.0); conference with
Company and AlixPartners re same (.3); draft
related correspondence re same (.2); analyze
and respond to correspondence re Dutch
matters (.5); analyze correspondence re
diligence, tax, and international matters (.3).
09/18/24 Donatus Wang 0.30 Review and analyze comments re structuring
of German asset sales.
09/19/24 Erin Davey 3.00 Research employment issues re sale.
09/19/24 Luke Finn 8.30 Review, analyze Company correspondence
regarding intercompany settlement plan and
German tax liability issues (1.1); review,
analyze Company correspondence regarding
Brazilian tax issues and asset transfer
structure (.7); review, analyze Company
correspondence regarding net economic
benefits plans, Dutch tax issues, and Local
Transfer Agreements (1.1); review, analyze
correspondence with Baker and McKenzie
Italy (.5); review, analyze correspondence
with Cooley regarding Checklist (.3); review,
analyze correspondence with Singapore and
Chinese counsel (.9); review, analyze
correspondence regarding confidential sale
(1.0); review, analyze correspondence with
Swiss counsel (1.2); review, analyze Cooley
checklist updates (.4); review, analyze
employee diligence with Company (.8);
review, analyze IP sales correspondence from
Company (.3).
09/19/24 Ruan J. Meintjes 1.00 Coordinate with K. Hardey re FDA regulatory
matters related to product removal (.8);
correspond with Company re California
manufacturing license (.2).
09/19/24 Carolin Paus 0.60 Research re merger clearance.
19
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 47 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/19/24 Carolin Paus 5.50 Review, analyze correspondence from S.
Toth, AlixPartners, Company re sales (3.4);
review, revise intercompany settlement
agreement (2.1).
09/19/24 Yusuf Salloum 1.00 Review, analyze issues re sale transactions.
09/19/24 Anna Schwander 0.80 Conference with Italian counsel re Italian FDI
filing.
09/19/24 Scottie Shermetaro 0.90 Correspond with Company re IP to be
excluded from Vents sale.
09/19/24 Steve Toth 2.50 Participate in advisor update telephone
conference with Company, AlixPartners, S.
Winters, K&E team (.3); discuss inventory
with AlixPartners (.2); participate in steering
committee teleconference with Company and
working group (.4); analyze and respond to
correspondence re international closing
matters and intercompany issues (1.1);
participate in special committee telephone
conference (.5).
09/20/24 Luke Finn 6.00 Review, analyze correspondence with
international local counsel, Company re
closing (1.4); review, analyze international
Vents IP filings (.1); attend conference re
closing (1.0); review, analyze sale question
(.4); attend conference re the same (.7);
review, analyze international entity wind-
down and Corporate Governance
considerations (.8); review, analyze officers’
certificate (.2); prepare for conference re
closing (.2); participating in conference re
same (.5); review, revise checklist (.3);
review, analyze correspondence re Brazil sale
(.4).
09/20/24 Trent Nachbar 2.20 Review, analyze closing checklist (.9); draft
ancillary documents (1.3).
09/20/24 Yusuf Salloum 2.00 Analyze issue re sale transactions.
09/20/24 Scottie Shermetaro 0.50 Review, analyze revised TSA Schedules.
20
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 48 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/20/24 Steve Toth 3.80 Participate in daily executive steering
committee teleconference with Company and
AlixPartners (.4); conference with Company
and L. Finn re IP (.1); analyze closing matters
(.2); discuss Brazil transaction with Company
and AlixPartners (.5); discuss closing‑critical
items with AlixPartners, L. Finn, K&E team
(.6); participate in teleconference re closing
checklist with Cooley, L. Finn, K&E team
(.5); analyze foreign correspondence re
closing matters (1.2); analyze and respond to
correspondence re TSA (.3).
09/21/24 Luke Finn 1.70 Correspond with local foreign counsel re sale
(.3); review, analyze Company
correspondence re Brazilian transaction (.9);
review, analyze correspondence regarding
Canadian entity transfer (.1); review, analyze
to Cooley correspondence (.4).
09/21/24 Trent Nachbar 1.70 Review, revise to closing checklist (.7); draft
ancillary documents (1.0).
09/21/24 Steve Toth 2.40 Analyze international matters.
09/22/24 Luke Finn 1.90 Review, analyze Dutch APA (.7); correspond
with S. Toth on the same (.1); correspond
with Dutch local counsel re same (.3) review,
analyze correspondence between Company
and Brazilian local counsel (.3); review,
analyze NDA re potential sale (.5).
09/22/24 Kate Hardey 1.60 Review, revise transaction notice letters for
customers and distributors.
09/22/24 Steve Toth 0.90 Analyze international closing matters (.4);
review, analyze documents re product line
termination (.5).
09/23/24 Luke Finn 3.90 Correspond with international local counsel
(.4); review and analyze Brazilian sale (.8);
review bidder documents (.5); correspond
with Cooley regarding IP matters (.4); review,
analyze intercompany settlement agreement
(.7); correspond with Cooley re checklist (.6);
review, analyze closing documents (.5).
09/23/24 Palmer Gunderson 0.80 Correspond with tax, corporate, and company
teams re pre-closing restructuring steps.
21
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 49 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/23/24 Carolin Paus 4.20 Review, analyze APAs re German legal issues
(2.4); review, analyze next steps re same (.6);
correspond with A. Ziegler, K&E team re
same (.5); review, analyze tax structuring
considerations under German law (.7).
09/23/24 Yusuf Salloum 3.50 Prepare for transaction closing.
09/23/24 Scottie Shermetaro 0.30 Correspond with Company re IP transfers.
09/23/24 Steve Toth 5.40 Analyze international matters and revise
attorney notes (.4); participate in daily
executive steering committee update
teleconference with AlixPartners, Company,
(.5); analyze correspondence re closing
matters and update attorney notes (.5)
participate in teleconference with lender
advisors, PJT, AlixPartners, Y. Salloum,
K&E team, and Company (.2); revise attorney
notes re closing issues (.3); participate in
advisors update teleconference (.3); revise
attorney notes (.3); analyze structure, tax and
closing issues (1.3); analyze tax and
international matters and related
correspondence (1.3); analyze revisions to
intercompany agreement (.3).
09/23/24 Nicholas Warther 0.50 Review and analyze structuring of
transaction.
09/23/24 Ann-Kathrin Ziegler 1.50 Review, revise sale documentation (1.2);
review, revise correspondence from S. Toth re
same (.3).
09/24/24 Chris Ceresa 1.50 Telephone conference with Y. Salloum, K&E
team, Cole Schotz re open sale legal issues.
22
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 50 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/24/24 Luke Finn 6.80 Conference with Cooley re sale (2.0);
conference with prospective purchaser,
Company re Brazilian sale (.8); review,
analyze Net Economic Benefit structure (.4);
review, analyze IP issues (.3); review, analyze
correspondence from local counsel re sale
(.5); review, analyze issues re Brazilian sale
(.2); review, analyze Brazilian Agility
contract question (.3); review, analyze
Intercompany Settlement Agreement (.5);
review, analyze correspondence re sale (.4);
review, analyze correspondence with German
counsel (.3); correspond with Company re
winddown planning (.7); review local counsel
correspondence re buyer export (.4).
09/24/24 Carolin Paus 3.20 Correspond with H. Braun, K&E team re sale
issues (.7); conference with D. Wang, K&E
team re works in process re sale (.9); draft
issues list re same (.5); research individual
asset sales (1.1).
09/24/24 Yusuf Salloum 3.00 Prepare for sale closing.
09/24/24 Scottie Shermetaro 0.30 Correspond with Company re transaction
planning.
09/24/24 Steve Toth 9.90 Analyze international updates (.3); participate
in all‑hands teleconference re transaction
issues (2.0); draft related correspondence (.2);
discuss regulatory and import matters with
Company AlixPartners, K. Hardey, K&E
team (.3); discuss legal issues and funds flow
with Cole Scholtz, AlixPartners, Y. Salloum,
K&E team (.8); discuss Brazil bidder with
Company, PJT, and AlixPartners (.4); analyze
correspondence re potential asset sale (.1);
correspond with AlixPartners, buyer,
Company, and Cole Schotz re lease matters
(.3); revise intercompany agreement (2.8),
discuss same with N. Warther (.8); further
revise same (1.4); prepare related
correspondence (.5).
09/24/24 Donatus Wang 1.10 Conference with A. Ziegler, K&E team re
APA and related documentation.
09/24/24 Nicholas Warther 0.80 Review and analyze structuring and APAs.
23
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 51 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/24/24 Ann-Kathrin Ziegler 1.00 Conference with D. Wang, K&E team re
German law documentation questions for
sales processes (.5); review and revise
correspondence re same (.5).
09/25/24 Bernadette Coppola 0.20 Correspond with S. Toth and K&E team re
revisions to license agreement and transition
services agreement.
09/25/24 Luke Finn 6.90 Attend conference with S. Toth, K&E team,
advisors re sale process (1.0); review, analyze
correspondence with AlixPartners re asset and
liability breakdown (.7); review, analyze
international asset transfers (1.4); review,
analyze sale issues (.8); correspond with
international counsel re sale process (.7);
review, analyze correspondence from
international local counsel (.4); review and
revise buyer officer certificate (.4); revise deal
checklist (.5); conference with Cooley re
same (1.0).
09/25/24 Trent Nachbar 0.80 Conference with Buyer’s counsel (.5); review,
revise officer’s certificates (.3).
09/25/24 Carolin Paus 1.70 Correspond with Company, A. Ziegler, K&E
team re German entities (.8); correspond with
A. Ziegler, K&E team re APAs and closing
(.9).
09/25/24 Yusuf Salloum 3.40 Prepare for sale closing.
09/25/24 Steve Toth 4.20 Analyze international updates (.1); conference
with AlixPartners and Cole Schotz re landlord
issues (.2); participate in all-hands telephone
conference re closing (1.1); analyze and
prepare correspondence re tax issues re sale
(.4); analyze and respond to correspondence
re A/R (.2); conference with Cooley re
bankruptcy and transaction issues (.4);
participate in telephone conference re closing
checklist with Cooley L. Finn, K&E team
(.5); revise intercompany settlement
agreement (.8); correspond with L. Finn,
K&E team, and Vyaire re Germany closing
matters (.3); analyze closing checklist (.2).
09/25/24 Cristina Weidner 2.40 Review, analyze APA re structuring
points (1.4); conference with various parties
re same (1.0).
24
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 52 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/25/24 Ann-Kathrin Ziegler 0.80 Review, revise correspondence from C. Paus
(.5); review, analyze correspondence from T.
Zehentbauer re APA (.3).
09/26/24 Chris Ceresa 0.70 Telephone conference with Y. Salloum, K&E
team, Cole Schotz team re open sale legal
issues.
09/26/24 Luke Finn 6.50 Prepare signature packets (1.7); attend
all‑hands conference (1.0); review, analyze
correspondence with India counsel (.3);
review, revise Malaysian Asset
Purchase Agreement (.5); correspond with
Company and Brazilian business
services/Intermed director team re transaction
(.8); review, analyze correspondence with
Singapore counsel (.6); review, analyze
correspondence with international local
counsel (.5); review, analyze Dutch Asset
Purchase (.3); correspond with Cooley re
transaction (.8).
09/26/24 Sabrina Lieberman 0.10 Correspond with C. Ceresa, S. Toth, K&E
team re standstill agreement.
09/26/24 Carolin Paus 7.00 Review and analyze correspondence from A.
Ziegler, K&E team, Company re sale issues
(.8); correspond with German local IP counsel
re IP issues (1.1); draft Asset Sale and
Transfer Agreement (3.8); discuss same with
H. Braun, K&E team (1.3).
09/26/24 Yusuf Salloum 3.20 Review, analyze issues re sale closing.
09/26/24 Steve Toth 2.80 Analyze closing issues (.2); analyze attorney
notes re intercompany agreement (2.6).
25
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 53 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/26/24 Steve Toth 5.10 Analyze international matters (.2); discuss
same with L. Finn (.2); participate in all hands
telephone conference re transaction issues
(.6); analyze closing matters, NEB and
distributor model (.3); participate in
teleconference with Company, PJT,
AlixPartners, Y. Salloum, K&E team re sale
update (.6) participate in executive steering
committee conference with Company and
AlixPartners re closing preparation (.3);
analyze intercompany agreement (.6); analyze
international closing documents (.4);
participate in special committee telephone
conference (.1); participate in all‑hands
telephone conference re transaction matters
(.6); participate in telephone conference with
Company, AlixPartners, Y. Salloum, K&E
team re closing issues (.4); correspond with
Y. Salloum, K&E team re inventory (.1);
discuss regulatory matters with AlixPartners,
K. Hardey, K&E team (.7).
09/26/24 Sarah Ullathorne 0.80 Review, analyze draft transfer agreement for
transfer of assets.
09/26/24 Donatus Wang 1.50 Prepare draft APAs.
09/26/24 Ann-Kathrin Ziegler 2.00 Review, analyze responses C. Ceresa, K&E
team re vents sale (.2); correspond with C.
Paus and D. Wang re next steps (.3);
correspond with C. Paus re IP firm (.4);
review, analyze correspondence from C.
Ceresa, K&E team re MIM sale (.4);
correspond with S. Ullathorne, K&E team re
APAs (.7).
09/27/24 Hendrik Braun 3.00 Review, analysis of German sale and transfer
agreements shares and assets.
09/27/24 Hendrik Braun 0.50 Review, analyze APAs re German share
transfers.
09/27/24 Chris Ceresa 0.80 Telephone conference with Y. Salloum, K&E
team, Cole Schotz team re open sale legal
issues.
09/27/24 Bernadette Coppola 0.50 Draft revisions to license agreement (.3);
correspond with buyer’s counsel and M.
King, S. Toth, K&E team re same (.2).
26
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 54 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/27/24 Luke Finn 6.50 Attend all‑hands conference (1.0); attend
conference with S. Toth, K&E team re closing
(.7); review, analyze Brazilian deal progress
correspondence (.2); review and revise
executed signature pages (.8); correspond
with local counsel and Company re
intercompany settlement (.6); review, analyze
Dutch Purchase Agreement draft and board
resolutions (.7); correspond with Company re
transactions (.3); compile surety bonds for
buyer (.4); review, analyze intercompany
settlement (.3); review, analyze
correspondence with Organização de
Despachos Feijo (.5) draft Escrow Instruction
Letter (.2); review, analyze updated schedule
of assumed and excluded contracts from
buyer (.4); review Wilmer Hale
correspondence re Brazilian and German
patent issues (.4).
09/27/24 Palmer Gunderson 0.70 Correspond with tax and accounting team re
pre-closing restructuring transactions.
09/27/24 Trent Nachbar 3.40 Revise list of in-scope entities.
09/27/24 Carolin Paus 7.50 Review, analyze issues re SPA (.8);
conference with German local IP counsel re
German IP (.5); review, analyze
correspondence from Company, AlixPartners,
M. Ehret, K&E team re transaction structure
(1.5); draft SPA (3.9); review and revise
APAs (.8).
09/27/24 Yusuf Salloum 3.50 Prepare for sale closings.
09/27/24 Scottie Shermetaro 2.00 Review and revise inter-business license
(1.5); correspond with opposing counsel re
same (.5).
27
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 55 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/27/24 Steve Toth 4.70 Participate in all‑hands telephone conference
re closing (1.1); analyze closing timing (.5);
discuss same with AlixPartners, Cole Schotz,
Y. Salloum, K&E team (.5); discuss closing
update with Company, AlixPartners, Y.
Salloum, K&E team (.6); prepare related
correspondence (.3); correspond with Cooley
re same (.1); discuss same with AlixPartners,
Cole Schotz, Y. Salloum, K&E team (.5);
prepare related correspondence (.4); analyze
responses (.4); revise intercompany
agreement (.3).
09/27/24 Donatus Wang 3.50 Prepare draft APAs for MIM SPA (1.0);
coordinate notarization of APAs (.5); discuss
related formalities and logistics with C. Paus,
K&E team and Company (.5); prepare APA
signing and notarization requirements (.5);
coordinate KYC check by German notary
(.5); correspond with A. Ziegler, K&E team
on same (.5).
09/27/24 Cristina Weidner 2.20 Review, analyze APA (1.0); review, analyze
SPA (.8); correspond with A. Ziegler, K&E
team re same (.4).
09/27/24 Ann-Kathrin Ziegler 1.50 Review, analyze draft German APA (.6);
review, analyze draft German SPA (.4);
correspond with C. Weidner, K&E team re
APAs (.5).
09/28/24 Luke Finn 2.00 Correspond with local counsel re Singapore
signatures (.5); correspond with Swiss
counsel re Closing (.3); review, analyze
Cooley draft of Dutch Purchase Agreement
(.7); review, analyze signature matrix and
entity review with T. Nachbar (.5).
09/28/24 Palmer Gunderson 1.40 Review and revise purchase price allocation
for sale transactions.
09/28/24 Palmer Gunderson 0.50 Correspond with tax and corporate team re
pre-closing restructuring planning.
09/28/24 Yusuf Salloum 2.00 Analyze issues re sale transaction.
09/28/24 Steve Toth 3.50 Analyze correspondence re closing and
intercompany matters (.7); update attorney
notes (.8); analyze intercompany agreement
(2.0).
28
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 56 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/28/24 Nicholas Warther 1.50 Telephone conference with BDO and KE
team re structuring of sale (.8); review and
analyze same (.7).
09/29/24 Michael Ehret 0.80 Correspond with S. Toth re vents transaction
(.2); conference with Cooley, buyer, S. Toth
in relation to closing of Vents APA, timing,
open items, next steps (.6).
09/29/24 Luke Finn 2.80 Attend advisor conference re transaction
update (1.1); correspond with local counsel re
sale issues (.2); review and respond to
comments by Swiss counsel on Dutch
Purchase Agreement (.4); review, analyze
transaction conference summary (.2); revise
checklist (.4); review, analyze Cooley updated
draft APA amendment and Schedule 3.11(a)
(.5).
09/29/24 Palmer Gunderson 1.50 Telephone conference with buyer tax counsel
re tax planning (.4); telephone conference
with N. Warther re purchase price allocation
(.2); revise purchase price allocation (.2);
correspond with tax, corporate, and company
teams re restructuring transactions and
purchase price allocation (.7).
09/29/24 Yusuf Salloum 2.00 Prepare for closing.
09/29/24 Scottie Shermetaro 0.20 Correspond with opposing counsel re
inter‑business license.
09/29/24 Steve Toth 6.90 Analyze closing issues update (.3); discuss
closing issues with AlixPartners, Y. Salloum,
K&E team (.9); prepare correspondence to Y.
Salloum, K&E team re issues list (.8);
participate in all hands teleconference re
closing timing and issues (1.3); prepare
related summary correspondence to Y.
Salloum, K&E team (.5); discuss update with
Company, AlixPartners, Y. Salloum, K&E
team (.6); analyze intercompany agreement
and related correspondence (.7); revise
intercompany agreement per Company and
advisor correspondence (1.8).
09/29/24 Nicholas Warther 1.80 Review and revise purchase price allocation
(.6); telephone conference with Deloitte, P.
Gunderson, K&E team re tax analysis (.7);
correspond with P. Gunderson, K&E team re
same (.5).
29
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 57 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/29/24 Sara B. Zablotney, P.C. 1.70 Attend telephone conference with Y. Salloum,
K&E team re purchase price (.5); attend all
hands status telephone conference re closing
(1.2).
09/30/24 Chris Ceresa 0.80 Telephone conference with Y. Salloum, K&E
team, Cole Schotz team re open legal issues re
sale.
09/30/24 Bernadette Coppola 0.50 Correspond with S. Toth, K&E team,
Company re amendment to asset purchase
agreement.
09/30/24 Anthony M. Del Rio 0.40 Review, analyze questions re transfer of
software and data to buyer.
09/30/24 Luke Finn 4.30 Attend all-hands conference re closing (1.0);
review, analyze Swiss correspondence (.4);
review, analyze Asset Transfers Agreement
update (.3); revise executed signature pages
(.7); revise, analyze Cooley correspondence re
intercompany settlement agreement (.3);
review, analyze Trench Rossi drafts of
Payment Agreement and Assignment
Agreements (.3); review, analyze Cooley
correspondence regarding international entity
asset transfers (.7); review, analyze updated
Italy matters (.2); review, analyze Clinical
Data Platform and Respiratory Knowledge
Portal matters (.4).
09/30/24 Palmer Gunderson 5.30 Correspond with S. Zablotney, K&E tax and
corporate team re pre-closing restructuring
(2.3); correspond with S. Toth, K&E
corporate team re sale transaction planning
(1.4); telephone conference with buyer tax
counsel (.3); correspond with accounting team
re tax allocation for sale transaction (.8);
revise tax allocation for sale transaction (.5).
09/30/24 Sabrina Lieberman 0.10 Correspond with C. Ceresa, A&M re
international counsel.
09/30/24 Trent Nachbar 3.20 Prepare transaction documents for execution.
09/30/24 Carolin Paus 3.80 Draft open issues list (.8); correspond with C.
Ceresa, K&E team, German notary re
required documents / formalities (.9); revise
German asset sale and transfer agreements
(1.1); prepare commercial register
documentation GmbH (1.0).
30
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 58 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107352
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property
Date Name Hours Description
09/30/24 Joshua Raphael 0.10 Review, analyze DIP, sale orders re
professional fees.
09/30/24 Yusuf Salloum 2.50 Review, analyze sale transactions.
09/30/24 Scottie Shermetaro 2.90 Review and revise amendment to the APA.
09/30/24 Steve Toth 5.60 Analyze APA amendment (.8); analyze
correspondence re schedules, IP and
amendment (.8); participate in all hands
teleconference re closing (.9); prepare related
correspondence (.1); participate in executive
steering committee teleconference with
Company, AlixPartners, Y. Salloum, K&E
team (.2); prepare related correspondence (.2);
participate in lender advisor conference with
AlixPartners, PJT, Y. Salloum, K&E team
(.1); analyze intercompany agreement (2.5).
09/30/24 Donatus Wang 1.60 Review and analyze foreign counsel
correspondence regarding German SPAs and
APAs for asset and shares sales under APAs,
transfer of German IP, KYC checks by
German notary.
09/30/24 Nicholas Warther 1.90 Telephone conference with Cooley tax re tax
elections for sale (.5); correspond with BDO
re same (.8); review and analyze purchase
price allocation (.6).
09/30/24 Sara B. Zablotney, P.C. 0.80 Review and analyze correspondence from S.
Toth, K&E team re closing.
09/30/24 Ann-Kathrin Ziegler 0.50 Correspond with C. Paus and D. Wang re next
steps on German sales documents /
workstreams.
Total 493.10
31
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 59 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107353
Client Matter: 48520-11
In the Matter of Executory Contracts & Unexpired Leases
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 14,052.50
Total legal services rendered $ 14,052.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 60 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107353
Vyaire Medical Inc. Matter Number: 48520-11
Executory Contracts & Unexpired Leases
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 1.60 1,395.00 2,232.00
Tiffani Chanroo 3.00 1,345.00 4,035.00
Hannah Crawford 2.30 1,595.00 3,668.50
Tabitha J. De Paulo 0.30 1,435.00 430.50
Jaina Desai 0.60 975.00 585.00
Luke Finn 1.30 1,345.00 1,748.50
Dan O'Connor 0.60 1,345.00 807.00
Steve Toth 0.30 1,820.00 546.00
TOTALS 10.00 $ 14,052.50
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 61 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107353
Vyaire Medical Inc. Matter Number: 48520-11
Executory Contracts & Unexpired Leases
Description of Legal Services
Date Name Hours Description
09/03/24 Chris Ceresa 0.20 Review, revise lease rejection motion.
09/04/24 Chris Ceresa 0.70 Review, revise lease rejection motion.
09/04/24 Tiffani Chanroo 0.80 Correspond with J. Desai re executory
contracts.
09/04/24 Tabitha J. De Paulo 0.30 Review, analyze issue re assumed contracts.
09/04/24 Jaina Desai 0.60 Correspond with K. Chiaghana re cure
objections (.2); correspond with AlixPartners
re same (.2); correspond with cure parties re
same (.2).
09/06/24 Tiffani Chanroo 1.20 Review, analyze executory contracts (.8);
correspond with J. Desai, counterparties re
same (.4).
09/06/24 Luke Finn 0.50 Review, respond to correspondence with Cole
Schotz re contract assignments.
09/08/24 Luke Finn 0.80 Correspond with C. Ceresa, K&E team lease
issues.
09/09/24 Tiffani Chanroo 0.40 Correspond with counterparty re executory
contracts (.1); review, analyze issues re same
(.3).
09/09/24 Hannah Crawford 0.50 Correspond with J. Mudhar re lease liabilities
in UK entity.
09/10/24 Chris Ceresa 0.70 Review and revise motion to extend lease
rejection deadline (.4); correspond with Cole
Schotz re same (.3).
09/10/24 Hannah Crawford 1.00 Correspond with J. Mudhar re UK lease (.3);
conference with AlixPartners re same (.7).
09/11/24 Tiffani Chanroo 0.60 Conference with Cole Schotz team re K+N.
09/11/24 Hannah Crawford 0.50 Conference with AlixPartners re UK lease.
09/13/24 Dan O'Connor 0.60 Telephone conferences with C. Ceresa and S.
Toth re Irvine lease matters.
09/13/24 Steve Toth 0.30 Discuss lease issues with AlixPartners and D.
O’Connor.
09/25/24 Hannah Crawford 0.30 Correspond with AlixPartners re UK Lease.
Total 10.00
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 62 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107354
Client Matter: 48520-12
In the Matter of Business Operations
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 40,634.50
Total legal services rendered $ 40,634.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 63 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107354
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 7.30 1,395.00 10,183.50
Tiffani Chanroo 2.10 1,345.00 2,824.50
Luke Finn 0.80 1,345.00 1,076.00
Kate Hardey 8.00 1,995.00 15,960.00
Olivia Kaufmann 3.30 1,095.00 3,613.50
Sabrina Lieberman 3.20 975.00 3,120.00
Jai Mudhar 0.20 1,345.00 269.00
Adrian Salmen 0.30 1,265.00 379.50
Steve Toth 1.30 1,820.00 2,366.00
Spencer A. Winters, P.C. 0.50 1,685.00 842.50
TOTALS 27.00 $ 40,634.50
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 64 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107354
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations
Description of Legal Services
Date Name Hours Description
09/02/24 Sabrina Lieberman 0.20 Correspond with statutory auditor candidate.
09/02/24 Jai Mudhar 0.20 Correspond with Baker McKenzie re Swiss
entity auditor issue.
09/03/24 Tiffani Chanroo 0.30 Correspond with S. Lieberman, K&E team re
Swiss Auditor.
09/03/24 Sabrina Lieberman 0.20 Correspond with AlixPartners, T. Chanroo,
K&E team re Swiss auditor.
09/04/24 Chris Ceresa 1.80 Review, analyze legal issues re Company
operations and communications (.8);
correspond with T. Chanroo, K&E team,
Company re issues re same (.3); review,
revise communications materials (.7).
09/04/24 Tiffani Chanroo 0.70 Conference with C. Ceresa, Company re
communications (.5); correspond with
Company re same (.2).
09/04/24 Luke Finn 0.80 Review of internal communications materials.
09/04/24 Sabrina Lieberman 0.20 Correspond with J. Mudhar, K&E team re
Swiss auditor.
09/04/24 Spencer A. Winters, P.C. 0.50 Prepare for and attend telephone conference
with AlixPartners re wind-down.
09/05/24 Chris Ceresa 1.70 Review, analyze legal issues re Company
operations and communications (.6);
correspond with T. Chanroo, K&E team,
Company re issues re same (.2); review,
revise communications materials (.9).
09/05/24 Tiffani Chanroo 0.30 Correspond with C. Ceresa, K&E team re
Swiss auditor.
09/05/24 Sabrina Lieberman 0.50 Correspond with T. Chanroo, K&E team re
Swiss auditor.
09/06/24 Chris Ceresa 0.60 Review, analyze legal issues re Company
operations and communications (.3);
correspond with T. Chanroo, K&E team,
Company re issues re same (.1); review,
revise communications materials (.2).
09/06/24 Tiffani Chanroo 0.80 Review, analyze issues re Swiss audit.
09/09/24 Chris Ceresa 1.20 Correspond with Company, Cole Schotz team
re business operations legal issues.
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 65 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107354
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations
Date Name Hours Description
09/09/24 Sabrina Lieberman 0.90 Conference with potential auditor,
AlixPartners, J. Mudhar, K&E team re Swiss
audit (.4); correspond with J. Mudhar, K&E
team re same (.5).
09/10/24 Chris Ceresa 1.10 Correspond with Company, Cole Schotz team
re business operations legal issues.
09/10/24 Sabrina Lieberman 0.40 Correspond with J. Mudhar, K&E team, Cole
Schotz, AlixPartners, prospective auditor,
Baker McKenzie re Swiss audit.
09/11/24 Kate Hardey 0.50 Prepare regulatory questions to EU counsel
(.3); review, analyze US products and FDA
reporting requirements (.2).
09/12/24 Chris Ceresa 0.30 Correspond with Company, Cole Schotz team
re business operations legal issues.
09/12/24 Sabrina Lieberman 0.30 Correspond with C. Ceresa, K&E team re
Swiss auditor.
09/16/24 Sabrina Lieberman 0.50 Correspond with C. Ceresa, local counsel,
Company re Swiss auditor.
09/19/24 Kate Hardey 1.40 Correspond with T. McDaniel re FDA
conference (.2); draft talking points re same
(1.0); conference with O. Kaufmann re review
of device shutdown process (.2).
09/19/24 Olivia Kaufmann 2.60 Research FDA guidance for company that
discontinues doing business (.6); research
precedent regarding same (1.2); conference
with K. Hardey regarding same (.8).
09/20/24 Kate Hardey 2.30 Participate in telephone conference with FDA
re device discontinuation requirements (.9);
conference with Company re same (.5);
review and revise customer FAQ (.6); prepare
customer adverse event notice language (.3).
09/20/24 Olivia Kaufmann 0.50 Attend conference with T. McDaniel, S.
Sridhar, and K. Hardey regarding conference
with FDA.
09/23/24 Chris Ceresa 0.30 Review, analyze legal issues re business
operations.
09/24/24 Kate Hardey 1.30 Conference with Company re product import
matters (1.0); correspond with various parties
re same (.3).
09/24/24 Olivia Kaufmann 0.20 Conference with K. Hardey regarding
regulatory question.
09/25/24 Chris Ceresa 0.30 Review, analyze legal issues re business
operations.
4
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 66 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107354
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations
Date Name Hours Description
09/26/24 Kate Hardey 1.20 Correspond with Company re various legacy
product regulatory issues.
09/27/24 Kate Hardey 1.30 Review, analyze product import invoices and
analysis of import requirements (1.0);
correspond with Company re same (.3).
09/27/24 Adrian Salmen 0.30 Correspond with insurer counsel, C. Ceresa,
K&E team re business operations.
09/27/24 Steve Toth 1.30 Discuss intercompany matters with Company
and N. Warther, K&E team (.7); analyze and
prepare related correspondence (.6).
Total 27.00
5
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 67 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107356
Client Matter: 48520-18
In the Matter of Insurance and Surety Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 46,107.00
Total legal services rendered $ 46,107.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 68 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107356
Vyaire Medical Inc. Matter Number: 48520-18
Insurance and Surety Matters
Summary of Hours Billed
Name Hours Rate Amount
Michael Ehret 20.10 1,895.00 38,089.50
Emanuel Goetz 7.90 750.00 5,925.00
Kate Hardey 1.00 1,995.00 1,995.00
Sabrina Lieberman 0.10 975.00 97.50
TOTALS 29.10 $ 46,107.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 69 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107356
Vyaire Medical Inc. Matter Number: 48520-18
Insurance and Surety Matters
Description of Legal Services
Date Name Hours Description
09/01/24 Michael Ehret 1.00 Correspond with Company re insurance
policy.
09/02/24 Michael Ehret 0.70 Correspond with Company re insurance (.2);
conference discussions with A. Skuratovski,
Marsh re same (.5).
09/03/24 Michael Ehret 0.70 Conference with A. Skuratovski, Marsh re
insurance (.5); conference with E. Goetz re
same (.2).
09/03/24 Emanuel Goetz 0.40 File various documents re German tax
insurance.
09/04/24 Michael Ehret 1.50 Conference with Company and advisors re
insurance policies.
09/05/24 Michael Ehret 1.70 Correspond with Deloitte re Certa insurance
policy (.3); review, analyze documents re
same (.4), attend conference with buyer team,
Deloitte re insurance coverage (1.0).
09/06/24 Michael Ehret 2.20 Review, revise draft insurance policy (1.0);
review, analyze Deloitte comments re same
(1.2).
09/06/24 Emanuel Goetz 3.20 Review, analyze Certa Policy Draft (3.0);
correspond with M. Ehret re same (.2).
09/10/24 Michael Ehret 1.90 Correspond with Deloitte re insurance (.1);
review, analyze documents re insurance
policy (1.0); conference with Deloitte, buyer,
Marsh re insurance policy, comments, next
steps (.5): conference with E. Goetz re
insurance policy (.3).
09/11/24 Michael Ehret 0.70 Review, analyze buyer correspondence re
insurance policy (.1); review, analyze revised
draft (.3); conference with E. Goetz re same
(.2); correspond with AlixPartners re same
(.1).
09/13/24 Michael Ehret 0.40 Correspond with AlixPartners, Marsh in
relation to revised insurance policy.
09/13/24 Emanuel Goetz 0.70 Review, analyze documents re Certa
underwriting process.
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 70 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107356
Vyaire Medical Inc. Matter Number: 48520-18
Insurance and Surety Matters
Date Name Hours Description
09/16/24 Michael Ehret 1.90 Prepare for conference with Certa re
insurance policy (.3); conference with Certa
re same (.9); correspond with E. Goetz re
same (.1); review, analyze correspondence
from N. Warther re purchase price allocation
(.6).
09/16/24 Emanuel Goetz 0.50 Review, analyze internal documents re Certa
underwriting process.
09/16/24 Emanuel Goetz 0.90 Conference with M. Ehret, Certa re tax
insurance.
09/17/24 Michael Ehret 0.50 Correspond with D. O’Connor, Company re
works in process.
09/18/24 Michael Ehret 2.00 Review, revise on revised insurance policy
received from Certa (1.0); conference with E.
Goetz re same (.7), correspond with Company
re same (.3).
09/19/24 Michael Ehret 1.70 Conference with Company re comments on
insurance policy (.4); draft correspondence to
buyer, Deloitte in relation to comments on
revised insurance policy (.2); correspond with
Company, D. O’Connor re status of policy
(.1); correspond with various parties re
insurance policy (.2); conference with E.
Goetz re amendments to insurance policy (.2);
review, analyze BDO steps paper (.3), draft
master agreement re settlement of
intercompany issues (.3).
09/20/24 Michael Ehret 0.50 Correspond with buyer/Deloitte re insurance
policy (.3) conference with E. Goetz re same
(.2).
09/20/24 Sabrina Lieberman 0.10 Correspond with Z. Manning, K&E team re
health plan issue.
09/23/24 Emanuel Goetz 0.90 Conference with M. Ehret, Certa re tax
insurance.
09/24/24 Michael Ehret 1.20 Review, analyze comments of Deloitte on
draft insurance policy (.8); conference with E.
Goetz re same (.3); correspond with A.
Skuratovski, Marsh re to revised draft policy
(.1).
09/24/24 Emanuel Goetz 0.70 Review, analyze tax insurance comments.
09/25/24 Emanuel Goetz 0.60 Review, analyze comments from Marsh on
potential tax insurance by Certa (.3);
correspond with M. Ehret re same (.3).
4
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 71 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107356
Vyaire Medical Inc. Matter Number: 48520-18
Insurance and Surety Matters
Date Name Hours Description
09/26/24 Michael Ehret 1.50 Review, analyze revised draft insurance
policy, (.8); conference with Deloitte, A.
Skuratovski, Marsh, E. Goetz re Certa
comments (.6); correspond buyer/Deloitte
team re same (.1).
09/30/24 Kate Hardey 1.00 Conference with Marsh re product liability
policies (.6); correspond with Company
advisors re same (.4).
Total 29.10
5
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 72 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107357
Client Matter: 48520-20
In the Matter of Tax Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 107,726.00
Total legal services rendered $ 107,726.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 73 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107357
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Summary of Hours Billed
Name Hours Rate Amount
Jaina Desai 0.10 975.00 97.50
Michael Ehret 10.40 1,895.00 19,708.00
Luke Finn 0.40 1,345.00 538.00
Emanuel Goetz 5.90 750.00 4,425.00
Palmer Gunderson 25.60 995.00 25,472.00
Sabrina Lieberman 0.50 975.00 487.50
Alex Stephenson 2.60 1,175.00 3,055.00
Nicholas Warther 23.00 1,665.00 38,295.00
Sara B. Zablotney, P.C. 6.40 2,445.00 15,648.00
TOTALS 74.90 $ 107,726.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 74 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107357
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Description of Legal Services
Date Name Hours Description
09/02/24 Palmer Gunderson 1.10 Correspond with Company re sale and tax
motion (.6); correspond with N. Warther,
K&E team re tax planning (.5).
09/02/24 Nicholas Warther 0.70 Correspond with Company re US tax
reporting items.
09/03/24 Emanuel Goetz 0.30 Revise draft ICO spreadsheet.
09/03/24 Palmer Gunderson 3.80 Review taxes motion re authorization for tax
planning activities (.7); correspond with
Company re tax planning activities (.5);
telephone conference with Company re tax
planning (.5); correspond with Company re
restructuring transactions (1.2); correspond
with BDO, N. Warther, S. Zablotney, K&E
team re tax planning activities (.9).
09/03/24 Nicholas Warther 0.80 Review and analyze structuring.
09/03/24 Sara B. Zablotney, P.C. 2.10 Attend telephone conference re purchase price
allocations and valuations (1.2); follow up re
structuring flexibility (.2); correspond with
AlixPartners, Company, K&E team re PPA
(.3); follow up re intercompany cleanup (.4).
09/04/24 Jaina Desai 0.10 Correspond with P. Gunderson re tax motion.
09/05/24 Nicholas Warther 4.20 Review and analyze purchase price allocation
(.9); telephone conference with Vyaire and
BDO re same and structuring (1.0); telephone
conference with S. Zablotney re same (.5);
review and analyze question re tax modeling
(.9); correspond with S. Zablotney, K&E team
and Company re intercompany resolutions
(.9).
09/06/24 Alex Stephenson 0.20 Discuss consolidated tax issue with N.
Warther.
09/09/24 Sabrina Lieberman 0.30 Correspond with Cole Schotz re IRS
correspondence.
09/09/24 Alex Stephenson 1.40 Research re consolidated loss treatment.
09/10/24 Palmer Gunderson 0.40 Correspond with N. Warther, K&E team re
structure slides and tax notice.
09/10/24 Nicholas Warther 0.40 Review and analyze tax return filing.
09/12/24 Nicholas Warther 0.50 Review and analyze BDO structure slides.
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 75 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107357
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Date Name Hours Description
09/13/24 Michael Ehret 2.10 Conference with E. Goetz re transaction
structure (.5); review, analyze BDO tax
memorandum (1.6).
09/13/24 Emanuel Goetz 1.40 Review, analyze slides re BDO tax
memorandum (.9); correspond with M. Ehret
re same (.5).
09/13/24 Palmer Gunderson 0.40 Correspond with working group re structure
slides and tax notice.
09/13/24 Alex Stephenson 1.00 Research re consolidated tax issues (.8);
conference with N. Warther re same (.2).
09/13/24 Nicholas Warther 1.30 Review and analyze structure slides (.4);
correspond with P. Gunderson, K&E team re
same (.3); review and analyze US tax
modeling question (.6).
09/16/24 Michael Ehret 0.10 Correspond with P. Gunderson re tax return
filings.
09/16/24 Emanuel Goetz 0.30 Correspond with M. Ehret the German tax
implications of transactions.
09/16/24 Emanuel Goetz 0.70 Correspond with M. Ehret re buyer notice.
09/16/24 Palmer Gunderson 0.80 Prepare update to company tax disclosure.
09/16/24 Nicholas Warther 0.70 Review and analyze structure slides.
09/16/24 Sara B. Zablotney, P.C. 0.50 Attend telephone conference re intercompany
issues.
09/17/24 Palmer Gunderson 3.30 Correspond with corporate team re novation
steps (.5); review and prepare tax comments
re intercompany settlement agreement (2.8).
09/17/24 Nicholas Warther 0.20 Correspond with P. Gunderson, K&E team re
status and next steps.
09/18/24 Emanuel Goetz 2.20 Review, analyze comments from Certa on the
tax insurance (1.9); review and discuss
outstanding issues with M. Ehret (.3).
09/18/24 Palmer Gunderson 0.40 Correspond with S. Zablotney, K&E tax team
and company re tax diligence update (.1);
correspond with S. Zablotney, K&E tax team
re settlement agreement (.3).
09/18/24 Sara B. Zablotney, P.C. 0.50 Review and revise Novation agreement.
09/19/24 Emanuel Goetz 0.30 Correspond with C. Paus re payment
structure.
09/19/24 Palmer Gunderson 0.70 Correspond with lenders counsel and
Company re tax diligence item (.4);
correspond with accounting team re
restructuring steps (.3).
4
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 76 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107357
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Date Name Hours Description
09/20/24 Sabrina Lieberman 0.20 Correspond with Company, Cole Schotz re
outstanding IRS requests.
09/23/24 Michael Ehret 1.80 Prepare for conference with buyer/Deloitte re
draft insurance policy, open items, (.8);
correspond with Deloitte re comments,
overview re determination of FMV (.3);
correspond with Company re status (.2);
review, analyze Company correspondence re
MIM shares timing (.5).
09/23/24 Palmer Gunderson 0.80 Correspond with Company re master
settlement agreement.
09/23/24 Nicholas Warther 3.00 Review and analyze structure slides (.8);
review and revise intercompany settlement
agreement (1.7); correspond with P.
Gunderson, K&E team and Company re same
(.5).
09/23/24 Sara B. Zablotney, P.C. 1.00 Correspond with N. Warther re intercompany
settlements.
09/24/24 Palmer Gunderson 0.20 Correspond with N. Warther, K&E team re
tax comments on settlement agreement.
09/24/24 Nicholas Warther 3.00 Review and revise intercompany settlement
agreement (2.1); correspond with BDO, P.
Gunderson, K&E team re US tax analysis
(.9).
09/25/24 Michael Ehret 2.20 Discussions with E. Goetz in relation to draft
novation/transfer agreement re intercompany
issues (1.6); review, analyze Marsh
correspondence re Certa insurance (.6).
09/25/24 Emanuel Goetz 0.70 Comment on intercompany settlement
agreement.
09/25/24 Palmer Gunderson 3.20 Analyze tax consequences of intercompany
obligation settlement transactions (2.0);
prepare draft tax treatment for settlement
agreement (1.2).
09/25/24 Nicholas Warther 2.70 Correspond with P. Gunderson, K&E team re
intercompany settlement agreement and
structuring (1.2); review and revise same (.4);
review and revise structure slides (.4);
correspond with P. Gunderson, K&E team re
structuring matters (.7).
09/25/24 Sara B. Zablotney, P.C. 0.90 Research Section 108(3)(6) (.3); review,
analyze correspond re closing (.6).
5
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 77 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107357
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Date Name Hours Description
09/26/24 Palmer Gunderson 5.40 Review, analyze tax treatment (2.4); review,
analyze BDO comments (3.0).
09/26/24 Nicholas Warther 2.50 Review and revise intercompany settlement
agreement (1.3); review and analyze US tax
consequences of same (.9); correspond with
P. Gunderson, K&E team re same (.3).
09/27/24 Michael Ehret 3.20 Correspond buyer/Deloitte team re comments
on insurance policy, finalization of policy
(.8); review, analyze draft novation agreement
(1.4); conference with Company, S. Toth, P.
Gunderson re various open items (.7);
correspond with C. Paus re open items (.3).
09/27/24 Palmer Gunderson 4.30 Telephone conference with Company re sale
and restructuring transactions (.5); telephone
conference with tax and accounting team re
tax treatment of restructuring transactions and
tax planning for restructuring (1.5); draft tax
comments on revised settlement agreement
(1.2); revise tax treatment language for
settlement agreement (1.1).
09/27/24 Nicholas Warther 1.80 Telephone conference with BDO re US tax
analysis (1.5); review and analyze same (.3).
09/27/24 Sara B. Zablotney, P.C. 0.40 Review, analyze intended tax treatment.
09/28/24 Luke Finn 0.40 Review, analyze Trent Rossi Intermed Tax &
Restructuring correspondence.
09/28/24 Palmer Gunderson 0.80 Telephone conference with S. Zablotney,
K&E tax team and Company (.5); review,
analyze revised settlement agreement (.3).
09/28/24 Sara B. Zablotney, P.C. 0.50 Attend telephone conference with P.
Gunderson, K&E tax team and Company re
intercompany settlements.
09/29/24 Nicholas Warther 0.80 Correspond with Company, P. Gunderson,
K&E team re intercompany settlements.
09/30/24 Michael Ehret 1.00 Review correspondence from Deloitte re
insurance (.5); correspond with A.
Skuratovski, Marsh re novation agreement
(.2); conference with C. Paus re asset transfers
(.3).
09/30/24 Nicholas Warther 0.40 Review and analyze intercompany settlement.
6
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 78 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107357
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters
Date Name Hours Description
09/30/24 Sara B. Zablotney, P.C. 0.50 Attend telephone conference with N. Warther,
K&E working group re intercompany
settlements.
Total 74.90
7
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 79 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107358
Client Matter: 48520-21
In the Matter of Case Administration
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 32,923.00
Total legal services rendered $ 32,923.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 80 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107358
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 4.50 1,395.00 6,277.50
Tiffani Chanroo 7.10 1,345.00 9,549.50
Erica D. Clark 0.40 1,595.00 638.00
Hannah Crawford 1.80 1,595.00 2,871.00
Jaina Desai 0.60 975.00 585.00
Michael Ehret 0.10 1,895.00 189.50
David Hackel 0.70 1,095.00 766.50
Kate Hardey 0.40 1,995.00 798.00
Sabrina Lieberman 3.00 975.00 2,925.00
Jai Mudhar 1.20 1,345.00 1,614.00
Joshua Raphael 2.60 1,095.00 2,847.00
Steve Toth 1.70 1,820.00 3,094.00
Donatus Wang 0.80 960.00 768.00
TOTALS 24.90 $ 32,923.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 81 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107358
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration
Description of Legal Services
Date Name Hours Description
09/03/24 Tiffani Chanroo 0.60 Conference with C. Ceresa re works in
process, case status.
09/03/24 Erica D. Clark 0.40 Conference with C. Ceresa, K&E team, Cole
Schotz re case status (.3); conference with
PJT re same (.1).
09/03/24 David Hackel 0.10 Review, analyze issues re service log,
stakeholder issues.
09/03/24 Kate Hardey 0.40 Correspond with R. Meintjes and S. Toth re
state license change of ownership
requirements for transaction.
09/03/24 Sabrina Lieberman 0.20 Review, revise works in process summary.
09/04/24 Sabrina Lieberman 1.50 Conference with Cole Schotz, C. Ceresa, T.
Chanroo re works in process (.5); correspond
with C. Schotz, C. Ceresa, K&E team re same
(.3); conference with C. Ceresa re same (.1);
draft correspondence to C. Ceresa, K&E team
re same (.6).
09/04/24 Joshua Raphael 0.40 Conference with C. Ceresa, T. Chanroo, CS re
coordination.
09/05/24 Jaina Desai 0.60 Revise case timeline (.5); correspond with C.
Ceresa, K. Trevett re same (.1).
09/05/24 Sabrina Lieberman 0.20 Correspond with C. Ceresa, K&E team re
works in process.
09/06/24 Tiffani Chanroo 0.50 Conference with Cole Schotz team, C. Ceresa
re works in process.
09/06/24 Hannah Crawford 0.50 Correspond with J. Mudhar re correspondence
to C. Ceresa.
09/06/24 Joshua Raphael 0.50 Telephone conference with C. Ceresa, K&E
team re case status, works in process.
09/09/24 Chris Ceresa 0.20 Telephone conference with J. Raphael and
Cole Schotz team re open case matters.
09/09/24 Joshua Raphael 0.20 Conference with C. Ceresa, Cole Schotz re
works in process.
09/10/24 Chris Ceresa 0.50 Telephone conference with J. Raphael and
Cole Schotz team re open case matters.
09/10/24 Tiffani Chanroo 1.20 Review, analyze reporting obligations (.8);
correspond with Cole Schotz team re same
(.4).
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 82 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107358
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration
Date Name Hours Description
09/10/24 Joshua Raphael 0.60 Telephone conference with C. Ceresa, Cole
Schotz re matter status.
09/11/24 Chris Ceresa 0.40 Telephone conference with Y. Salloum re
open case items.
09/11/24 Chris Ceresa 0.60 Telephone conference with J. Raphael and
Cole Schotz team re open case matters.
09/11/24 Tiffani Chanroo 1.30 Conference with Cole Schotz team, C. Ceresa
re case status (.6); review, analyze issues re
same (.7).
09/11/24 Joshua Raphael 0.50 Telephone conference with C. Ceresa, K&E
team re open issues.
09/12/24 Chris Ceresa 1.10 Telephone conferences with Y. Salloum, S.
Toth, K&E team, advisors, counsel re open
case issues.
09/12/24 Hannah Crawford 0.80 Conference with J. Mudhar, K&E team, Cole
Schotz re works in process (.5); correspond
with J. Mudhar, K&E team re same (.3).
09/12/24 Sabrina Lieberman 0.80 Conference with Cole Schotz, C. Ceresa,
K&E team re works in process.
09/12/24 Jai Mudhar 0.50 Conference with Cole Schotz on international
workstreams.
09/13/24 Hannah Crawford 0.50 Conference with J. Mudhar, K&E team, Cole
Schotz re works in process.
09/13/24 Sabrina Lieberman 0.20 Conference with S. Osborne re works in
process (.1); correspond with S. Osborne re
same (.1).
09/13/24 Jai Mudhar 0.50 Conference with Cole Schotz, H. Crawford,
K&E team re works in process.
09/13/24 Donatus Wang 0.80 Conference with C. Ceresa, K&E team re
works in process.
09/16/24 Chris Ceresa 0.30 Telephone conference with Cole Schotz team
re open legal matters.
09/17/24 Chris Ceresa 0.40 Telephone conference with Y. Salloum re
case status.
09/17/24 Chris Ceresa 0.40 Telephone conference with Cole Schotz team
re open legal matters.
09/17/24 Tiffani Chanroo 1.70 Conference with C. Ceresa, Cole Schotz team
re works in process (.5); conference with C.
Ceresa re case status, works in process (.6);
review, analyze correspondence from C.
Ceresa re works in process (.6).
4
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 83 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107358
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration
Date Name Hours Description
09/17/24 Michael Ehret 0.10 Correspond with Company advisors re
insurance policy (.5); correspond with D.
O’Connor, Company re works in process (.1).
correspond with Deloitte, buyer re transaction
(.1).
09/17/24 Jai Mudhar 0.20 Conference with S. Lieberman re Swiss
auditor issues.
09/17/24 Joshua Raphael 0.40 Conference with C. Ceresa, Cole Schotz re
priority items.
09/18/24 Chris Ceresa 0.20 Telephone conference with Cole Schotz team
re open legal matters.
09/18/24 Tiffani Chanroo 0.40 Conference with C. Ceresa, Cole Schotz team
re case status.
09/19/24 Chris Ceresa 0.40 Telephone conference with Cole Schotz team
re open legal matters.
09/21/24 Sabrina Lieberman 0.10 Review, analyze correspondence from C.
Ceresa, K&E team re works in process.
09/23/24 Tiffani Chanroo 0.10 Review, analyze correspondence from C.
Ceresa re case status.
09/23/24 Steve Toth 0.30 Participate in telephone conference with Cole
Schotz, AlixPartners, and working group re
case matters.
09/25/24 Tiffani Chanroo 0.30 Correspond with D. Hackel re Omni requests.
09/25/24 David Hackel 0.30 Analyze issues re stakeholder log (.2);
correspond with T. Chanroo, K&E team re
same (.1).
09/25/24 Steve Toth 1.10 Conference with Y. Salloum, K&E team,
Cole Schotz, AlixPartners re case updates
(.5); draft related correspondence (.6).
09/26/24 Tiffani Chanroo 1.00 Review, analyze correspondence from C.
Ceresa re case status.
09/26/24 David Hackel 0.30 Analyze issues re stakeholder log (.2);
correspond with S. Osborne re same (.1).
09/26/24 Steve Toth 0.30 Participate in update telephone conference
with PJT, AlixPartners, N. Warther, K&E
team.
Total 24.90
5
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 84 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107359
Client Matter: 48520-22
In the Matter of Retention - K&E
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 100,920.00
Total legal services rendered $ 100,920.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 85 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107359
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 27.50 1,395.00 38,362.50
Tiffani Chanroo 8.30 1,345.00 11,163.50
Jaina Desai 6.80 975.00 6,630.00
Julia R. Foster 0.90 525.00 472.50
David Hackel 6.10 1,095.00 6,679.50
Sabrina Lieberman 21.10 975.00 20,572.50
Sarah Osborne 1.40 975.00 1,365.00
Adrian Salmen 5.30 1,265.00 6,704.50
Seth Sanders 4.00 1,265.00 5,060.00
Kyle Nolan Trevett 1.80 1,265.00 2,277.00
Tanzila Zomo 4.60 355.00 1,633.00
TOTALS 87.80 $ 100,920.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 86 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107359
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E
Description of Legal Services
Date Name Hours Description
09/01/24 Sabrina Lieberman 2.20 Review, revise K&E invoice for privilege,
confidentiality.
09/02/24 Sabrina Lieberman 3.50 Review, revise K&E invoice re privilege,
confidentiality.
09/03/24 Sabrina Lieberman 0.70 Review, revise K&E invoice re privilege,
confidentiality.
09/05/24 Chris Ceresa 0.20 Review, analyze status re K&E fee
application.
09/05/24 Sabrina Lieberman 1.30 Review, revise invoice for privilege and
confidentiality (1.0); correspond with C.
Ceresa, K&E team re same (.3).
09/08/24 Sabrina Lieberman 0.30 Draft correspondence to S. Winters re fee
application (.1); correspond with J. Foster,
K&E team re same (.2).
09/09/24 Sabrina Lieberman 0.20 Correspond with S. Winters, K&E team re fee
application.
09/11/24 Sabrina Lieberman 1.30 Review, revise invoice re privilege and
confidentiality (1.1); correspond with T.
Chanroo, K&E team re same (.2).
09/12/24 Sabrina Lieberman 0.10 Correspond with C. Ceresa re second
supplemental declaration in support of K&E
retention.
09/12/24 Adrian Salmen 2.40 Review, revise K&E invoice for privilege and
confidentiality.
09/13/24 Adrian Salmen 1.60 Review, revise K&E invoice for privilege and
confidentiality.
09/13/24 Seth Sanders 2.10 Review, revise K&E invoice for privilege and
confidentiality.
09/13/24 Kyle Nolan Trevett 0.60 Review, revise K&E invoice re privilege,
confidentiality issues (.5); correspond with S.
Lieberman, K&E team re same (.1).
09/14/24 Kyle Nolan Trevett 0.50 Review, revise invoice re privilege,
confidentiality.
09/16/24 Chris Ceresa 4.40 Review, revise K&E monthly fee statement
entries for confidentiality and privilege issues
(3.9); correspond with S. Lieberman and
K&E team re same (.5).
09/16/24 Tiffani Chanroo 2.00 Review, revise K&E invoice re privilege and
confidentiality considerations.
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 87 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107359
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E
Date Name Hours Description
09/17/24 Chris Ceresa 1.50 Review, revise on K&E monthly fee
statement entries for confidentiality and
privilege issues (1.2); correspond with S.
Lieberman and K&E team re same (.3).
09/18/24 Tiffani Chanroo 0.20 Correspond with S. Lieberman re interim fee
application.
09/18/24 Tanzila Zomo 2.00 Draft initial interim fee application.
09/19/24 Chris Ceresa 2.80 Review, revise K&E monthly fee statement
entries for confidentiality and privilege issues
(2.6); correspond with S. Lieberman and
K&E team re same (.2).
09/19/24 David Hackel 3.90 Review, revise K&E invoice re privilege,
confidentiality.
09/19/24 Sabrina Lieberman 1.40 Review, revise invoice for privilege and
confidentiality (1.1); review, revise interim
fee application (.3).
09/20/24 Chris Ceresa 1.60 Review, revise, comment on K&E monthly
fee statement entries for confidentiality and
privilege issues (1.3); correspond with S.
Lieberman and K&E team re same (.3).
09/20/24 David Hackel 2.20 Review, revise K&E invoice re privilege,
confidentiality.
09/21/24 Tiffani Chanroo 0.50 Review, revise invoice for confidentiality and
privilege considerations.
09/21/24 Sabrina Lieberman 0.70 Review, revise first interim fee application.
09/21/24 Sarah Osborne 1.40 Review, revise K&E invoice for privilege,
confidentiality concerns.
09/22/24 Tiffani Chanroo 1.50 Review, revise invoice for privilege and
confidentiality considerations.
09/22/24 Jaina Desai 5.40 Review, revise invoice re privilege and
confidentially considerations (3.9); further
review, revise invoice re same (1.3);
correspond with S. Lieberman re same (.1);
correspond with K. Trevett re same (.1).
09/23/24 Chris Ceresa 4.70 Review, revise K&E fee statement for
privilege and confidentiality issues (3.9);
correspond with S. Lieberman and K&E team
re same (.8).
09/23/24 Tiffani Chanroo 4.10 Review, revise K&E invoice for
confidentiality and privilege (3.9); correspond
with C. Ceresa, K&E team re same (.2).
4
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 88 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107359
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E
Date Name Hours Description
09/23/24 Jaina Desai 1.40 Review, revise invoice re privilege and
confidentially considerations (1.0);
correspond with K. Trevett, K&E team re
same (.4).
09/23/24 Adrian Salmen 1.30 Review, revise K&E invoice re privilege and
confidentiality.
09/23/24 Seth Sanders 1.90 Revise K&E invoice re privilege &
confidentiality.
09/23/24 Kyle Nolan Trevett 0.70 Review, revise invoice re privilege,
confidentiality (.6); correspond with S.
Lieberman, K&E team re same (.1).
09/24/24 Chris Ceresa 1.20 Review, revise K&E fee statement for
privilege and confidentiality issues (1.1);
correspond with S. Lieberman and K&E team
re same (.1).
09/24/24 Julia R. Foster 0.90 Research precedent re K&E interim fee
application.
09/24/24 Sabrina Lieberman 2.90 Review, revise interim fee application.
09/24/24 Tanzila Zomo 2.00 Research re first interim fee application.
09/25/24 Chris Ceresa 0.40 Review, revise K&E fee statement for
privilege and confidentiality issues (.3);
correspond with S. Lieberman and K&E team
re same (.1).
09/25/24 Sabrina Lieberman 2.70 Review, revise interim fee application.
09/25/24 Tanzila Zomo 0.60 Review, revise interim fee application.
09/27/24 Chris Ceresa 2.60 Review, revise K&E fee statement for
privilege and confidentiality issues (2.4);
correspond with S. Lieberman and K&E team
re same (.2).
09/27/24 Sabrina Lieberman 0.10 Correspond with C. Ceresa, AlixPartners re
payment.
09/28/24 Sabrina Lieberman 0.70 Review, revise K&E invoice re privilege,
confidentiality.
09/29/24 Sabrina Lieberman 3.00 Review, revise K&E invoice re privilege and
confidentiality.
09/30/24 Chris Ceresa 8.10 Review, revise K&E fee statement for
privilege and confidentiality issues (3.9);
further review and revise same (3.7);
correspond with S. Lieberman and K&E team
re same (.5).
Total 87.80
5
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 89 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107360
Client Matter: 48520-23
In the Matter of Retention - Non K&E
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 3,108.00
Total legal services rendered $ 3,108.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 90 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107360
Vyaire Medical Inc. Matter Number: 48520-23
Retention - Non K&E
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 1.30 1,395.00 1,813.50
Tiffani Chanroo 0.60 1,345.00 807.00
Sabrina Lieberman 0.50 975.00 487.50
TOTALS 2.40 $ 3,108.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 91 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107360
Vyaire Medical Inc. Matter Number: 48520-23
Retention - Non K&E
Description of Legal Services
Date Name Hours Description
09/03/24 Sabrina Lieberman 0.20 Review, analyze correspondence from C.
Ceresa, PJT re fee statements.
09/09/24 Tiffani Chanroo 0.60 Review, analyze BDO monthly fee statement
(.4); correspond with Cole Schotz team re
same (.2).
09/13/24 Chris Ceresa 1.10 Telephone conference with AlixPartners, Cole
Schotz re professional fees planning and
issues.
09/25/24 Chris Ceresa 0.20 Correspond with S. Lieberman re non-K&E
retention filings.
09/25/24 Sabrina Lieberman 0.30 Review, analyze PJT fee application.
Total 2.40
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 92 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107361
Client Matter: 48520-24
In the Matter of Vendor Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 6,135.50
Total legal services rendered $ 6,135.50
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 93 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107361
Vyaire Medical Inc. Matter Number: 48520-24
Vendor Matters
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 2.00 1,395.00 2,790.00
Tiffani Chanroo 0.30 1,345.00 403.50
Sabrina Lieberman 0.10 975.00 97.50
Steve Toth 1.10 1,820.00 2,002.00
Spencer A. Winters, P.C. 0.50 1,685.00 842.50
TOTALS 4.00 $ 6,135.50
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 94 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107361
Vyaire Medical Inc. Matter Number: 48520-24
Vendor Matters
Description of Legal Services
Date Name Hours Description
09/03/24 Tiffani Chanroo 0.30 Correspond with K. Chiaghana re possessory
liens.
09/03/24 Sabrina Lieberman 0.10 Conference with vendor counsel re status
update.
09/04/24 Steve Toth 0.60 Correspond with Company, AlixPartners, and
K&E team re vendors.
09/04/24 Spencer A. Winters, P.C. 0.50 Telephone conference with Company,
AlixPartners team re vendors.
09/16/24 Chris Ceresa 0.70 Review, analyze open legal issues with
vendors and counterparties.
09/17/24 Chris Ceresa 1.30 Review, analyze open legal issues with
vendors and counterparties.
09/27/24 Steve Toth 0.50 Correspond with Company, AlixPartners, and
Cole Schotz re vendor issues.
Total 4.00
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 95 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107362
Client Matter: 48520-25
In the Matter of Litigation
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 6,813.00
Total legal services rendered $ 6,813.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 96 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107362
Vyaire Medical Inc. Matter Number: 48520-25
Litigation
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 1.30 1,395.00 1,813.50
Tabitha J. De Paulo 0.50 1,435.00 717.50
Alisa Melekhina 0.60 1,595.00 957.00
Maureen D. O'Brien 1.40 2,115.00 2,961.00
Steve Toth 0.20 1,820.00 364.00
TOTALS 4.00 $ 6,813.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 97 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107362
Vyaire Medical Inc. Matter Number: 48520-25
Litigation
Description of Legal Services
Date Name Hours Description
09/03/24 Chris Ceresa 0.40 Review, revise removal motion (.2);
correspond with T. Chanroo, K&E team re
issues re same (.2).
09/04/24 Chris Ceresa 0.90 Review, revise removal motion (.5);
correspond with T. Chanroo, K&E team re
issues re same (.4).
09/17/24 Alisa Melekhina 0.10 Review, analyze production links and
transmittals.
09/17/24 Maureen D. O'Brien 1.40 Conference with S. Kim, K&E team
employment matters (.5); review, analyze
research re: same (.5); review plan documents
(.4).
09/18/24 Tabitha J. De Paulo 0.10 Correspond with various parties re discovery
responses.
09/20/24 Tabitha J. De Paulo 0.20 Review and revise responses and objections
to discovery requests.
09/25/24 Tabitha J. De Paulo 0.20 Conference with Company re potential
litigation funding.
09/25/24 Steve Toth 0.20 Discuss litigation with AlixPartners, Y.
Salloum, K&E team Company.
09/27/24 Alisa Melekhina 0.50 Review, analyze objections and responses to
the UCC discovery requests (.2); review,
analyze Cole Schotz and UCC meet and
confer updates (.2); correspond with various
parties on document productions and follow-
up requests (.1).
Total 4.00
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 98 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
October 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107363
Client Matter: 48520-26
In the Matter of Expenses
For expenses incurred through September 30, 2024
(see attached Description of Expenses for detail) $ 7,859.33
Total expenses incurred $ 7,859.33
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 99 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Description of Expenses
Description Amount
Standard Copies or Prints 51.20
Color Copies or Prints 304.70
Local Transportation 212.99
Airfare 1,097.62
Transportation to/from airport 1,239.88
Outside Printing Services 1,771.48
Computer Database Research 1,129.00
Westlaw Research 331.15
LexisNexis Research 1,348.49
Overtime Transportation 275.54
Overtime Meals - Attorney 86.38
Computer Database Research - Soft 10.90
Total $ 7,859.33
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 100 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Description of Expenses
Standard Copies or Prints
Date Description Amount
08/01/24 Standard Copies or Prints 0.60
08/01/24 Standard Copies or Prints 0.10
08/05/24 Standard Copies or Prints 1.20
08/08/24 Standard Copies or Prints 9.90
08/12/24 Standard Copies or Prints 0.40
08/13/24 Standard Copies or Prints 0.80
08/14/24 Standard Copies or Prints 0.30
08/14/24 Standard Copies or Prints 0.20
08/15/24 Standard Copies or Prints 0.20
08/22/24 Standard Copies or Prints 0.40
08/23/24 Standard Copies or Prints 0.50
08/26/24 Standard Copies or Prints 0.50
08/28/24 Standard Copies or Prints 0.20
08/28/24 Standard Copies or Prints 0.40
08/29/24 Standard Copies or Prints 0.50
09/03/24 Standard Copies or Prints 0.30
09/04/24 Standard Copies or Prints 0.20
09/04/24 Standard Copies or Prints 0.10
09/05/24 Standard Copies or Prints 6.20
09/11/24 Standard Copies or Prints 0.20
09/11/24 Standard Copies or Prints 1.80
09/12/24 Standard Copies or Prints 0.80
09/13/24 Standard Copies or Prints 0.30
09/13/24 Standard Copies or Prints 1.20
09/17/24 Standard Copies or Prints 0.80
09/18/24 Standard Copies or Prints 6.30
09/18/24 Standard Copies or Prints 0.90
09/23/24 Standard Copies or Prints 0.70
09/23/24 Standard Copies or Prints 0.30
09/23/24 Standard Copies or Prints 2.70
09/24/24 Standard Copies or Prints 1.60
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 101 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
09/24/24 Standard Copies or Prints 0.90
09/25/24 Standard Copies or Prints 5.30
09/25/24 Standard Copies or Prints 0.70
09/25/24 Standard Copies or Prints 0.50
09/26/24 Standard Copies or Prints 0.70
09/26/24 Standard Copies or Prints 1.90
09/27/24 Standard Copies or Prints 0.40
09/30/24 Standard Copies or Prints 0.20
Total 51.20
4
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 102 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Color Copies or Prints
Date Description Amount
08/01/24 Color Copies or Prints 0.55
08/01/24 Color Copies or Prints 25.85
08/03/24 Color Copies or Prints 9.90
08/13/24 Color Copies or Prints 1.10
08/13/24 Color Copies or Prints 11.55
08/13/24 Color Copies or Prints 2.20
08/22/24 Color Copies or Prints 15.95
08/28/24 Color Copies or Prints 22.00
08/28/24 Color Copies or Prints 17.60
09/05/24 Color Copies or Prints 23.10
09/06/24 Color Copies or Prints 21.45
09/11/24 Color Copies or Prints 22.55
09/12/24 Color Copies or Prints 0.55
09/12/24 Color Copies or Prints 20.90
09/13/24 Color Copies or Prints 20.35
09/13/24 Color Copies or Prints 17.60
09/18/24 Color Copies or Prints 1.10
09/23/24 Color Copies or Prints 1.65
09/24/24 Color Copies or Prints 24.20
09/24/24 Color Copies or Prints 22.00
09/24/24 Color Copies or Prints 4.95
09/25/24 Color Copies or Prints 5.50
09/25/24 Color Copies or Prints 3.85
09/26/24 Color Copies or Prints 1.10
09/26/24 Color Copies or Prints 0.55
09/30/24 Color Copies or Prints 6.60
Total 304.70
5
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 103 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Local Transportation
Date Description Amount
09/06/24 Chris Ceresa – transportation for hearing 212.99
Total 212.99
6
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 104 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Airfare
Date Description Amount
08/20/24 Spencer A. Winters, P.C. - airfare (coach) to hearing 678.94
08/29/24 Spencer A. Winters, P.C. - airfare (coach) to hearing 418.68
Total 1,097.62
7
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 105 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Transportation to/from airport
Date Description Amount
08/31/24 Tabitha DePaulo – transportation from airport to residence 132.90
09/05/24 Tabitha De Paulo – transportation from airport to hotel 181.75
09/05/24 Spencer Winters – transportation from airport to residence 137.05
09/05/24 Spencer Winters – transportation from airport to hotel 225.93
09/05/24 Tabitha De Paulo – transportation from airport to hotel 206.75
09/05/24 Spencer Winters transport from local office to airport 181.75
09/05/24 Spencer Winters – transportation from hotel to airport 173.75
Total 1,239.88
8
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 106 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Outside Printing Services
Date Description Amount
06/12/24 RELIABLE WILMINGTON - Outside printing for Vyaire 1,523.08
06/12/24 RELIABLE WILMINGTON - Outside printing for Vyaire 248.40
Total 1,771.48
9
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 107 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Computer Database Research
Date Description Amount
08/09/24 RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets 167.00
Usage for 07/2024 by Joshua Raphael
08/09/24 RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets 99.00
Usage for 07/2024 by David Hackel
08/09/24 RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets 837.00
Usage for 07/2024 by Sarah Osborne
08/09/24 RESTRUCTURING CONCEPTS LLC - Chapter 11 Dockets 26.00
Usage for 07/2024 by Rebecca Marston
Total 1,129.00
10
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 108 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Westlaw Research
Date Description Amount
08/08/24 THOMSON REUTERS - WEST PUBLISHING CORP - 28.57
WESTLAW Research Charges by Wetzel, Quin on 8/8/2024
08/08/24 THOMSON REUTERS - WEST PUBLISHING CORP - 8.58
WESTLAW Research Charges by Raphael, Joshua on 8/8/2024
08/11/24 THOMSON REUTERS - WEST PUBLISHING CORP - 28.57
WESTLAW Research Charges by Marston, Rebecca on 8/11/2024
08/12/24 THOMSON REUTERS - WEST PUBLISHING CORP - 37.12
WESTLAW Research Charges by Chanroo, Tiffani on 8/12/2024
08/26/24 THOMSON REUTERS - WEST PUBLISHING CORP - 57.08
WESTLAW Research Charges by Raphael, Joshua on 8/26/2024
08/27/24 THOMSON REUTERS - WEST PUBLISHING CORP - 114.15
WESTLAW Research Charges by Raphael, Joshua on 8/27/2024
08/28/24 THOMSON REUTERS - WEST PUBLISHING CORP - 57.08
WESTLAW Research Charges by Raphael, Joshua on 8/28/2024
Total 331.15
11
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 109 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
LexisNexis Research
Date Description Amount
08/04/24 RELX Inc DBA LexisNexis - LexisNexis Research on 8/4/2024 by 192.50
Nicholas Warther
08/08/24 RELX Inc DBA LexisNexis - LexisNexis Research on 8/8/2024 by 335.46
Joshua Raphael
08/20/24 RELX Inc DBA LexisNexis - LexisNexis Research on 8/20/2024 57.77
by Palmer Gunderson
08/22/24 RELX Inc DBA LexisNexis - LexisNexis Research on 8/22/2024 308.04
by Palmer Gunderson
08/26/24 RELX Inc DBA LexisNexis - LexisNexis Research on 8/26/2024 155.15
by Joshua Raphael
08/27/24 RELX Inc DBA LexisNexis - LexisNexis Research on 8/27/2024 144.42
by Palmer Gunderson
08/28/24 RELX Inc DBA LexisNexis - LexisNexis Research on 8/28/2024 155.15
by Joshua Raphael
Total 1,348.49
12
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 110 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Overtime Transportation
Date Description Amount
09/03/24 Quin Wetzel - overtime transportation 19.56
09/05/24 Nicholas Warther - overtime transportation 68.03
09/23/24 Steve Toth - overtime transportation 33.00
09/24/24 Steve Toth - overtime transportation (evening) 19.92
09/24/24 Steve Toth - overtime transportation (morning) 24.60
09/25/24 Steve Toth - overtime transportation (evening) 26.48
09/25/24 Steve Toth - overtime transportation (morning) 27.14
09/26/24 Steve Toth - overtime transportation (evening) 21.13
09/26/24 Steve Toth - overtime transportation (morning) 35.68
Total 275.54
13
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 111 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Overtime Meals - Attorney
Date Description Amount
08/06/24 Alma Chan – overtime meal 20.00
09/03/24 Quin Wetzel - overtime meal 20.00
09/19/24 Nicholas Warther - Nicholas Warther - overtime meal 20.00
09/24/24 Steve Toth - overtime meal 14.91
09/26/24 Steve Toth - overtime meal 11.47
Total 86.38
14
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 112 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107363
Vyaire Medical Inc. Matter Number: 48520-26
Expenses
Computer Database Research - Soft
Date Description Amount
06/01/24 PACER Usage for 06/2024 0.70
08/01/24 PACER Usage for 08/2024 10.20
Total 10.90
TOTAL EXPENSES $ 7,859.33
15
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 113 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107364
Client Matter: 48520-28
In the Matter of Creditors’ Committee Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 4,963.00
Total legal services rendered $ 4,963.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 114 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107364
Vyaire Medical Inc. Matter Number: 48520-28
Creditors’ Committee Matters
Summary of Hours Billed
Name Hours Rate Amount
Chris Ceresa 2.30 1,395.00 3,208.50
Alisa Melekhina 0.10 1,595.00 159.50
Yusuf Salloum 1.00 1,595.00 1,595.00
TOTALS 3.40 $ 4,963.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 115 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107364
Vyaire Medical Inc. Matter Number: 48520-28
Creditors’ Committee Matters
Description of Legal Services
Date Name Hours Description
09/17/24 Chris Ceresa 0.20 Review, analyze UCC requests for production
and interrogatories.
09/17/24 Alisa Melekhina 0.10 Review, analyze Cole Schotz and UCC
updates and correspondence.
09/17/24 Yusuf Salloum 1.00 Review, analyze document and production
requests.
09/18/24 Chris Ceresa 1.80 Review, analyze UCC requests for production
and interrogatories.
09/21/24 Chris Ceresa 0.30 Review, analyze UCC requests for production
and interrogatories.
Total 3.40
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 116 of 120
601 Lexington Avenue
New York, NY 10022
FEIN 36-1326630
November 20, 2024
Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045
Attn: Vikram Bajaj
Invoice Number: 1050107365
Client Matter: 48520-29
In the Matter of Employee and Labor Matters
For legal services rendered through September 30, 2024
(see attached Description of Legal Services for detail) $ 55,069.00
Total legal services rendered $ 55,069.00
Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 117 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107365
Vyaire Medical Inc. Matter Number: 48520-29
Employee and Labor Matters
Summary of Hours Billed
Name Hours Rate Amount
Rebecca H. Arnall 1.50 1,265.00 1,897.50
Chris Ceresa 4.20 1,395.00 5,859.00
Jaina Desai 0.50 975.00 487.50
Luke Finn 0.80 1,345.00 1,076.00
Kate Hardey 0.70 1,995.00 1,396.50
Sooah Kim 1.90 1,095.00 2,080.50
Maureen D. O'Brien 4.50 2,115.00 9,517.50
Scott D. Price, P.C. 0.50 2,245.00 1,122.50
Risa Salins 13.00 2,115.00 27,495.00
Paul Vasiloff 2.70 1,345.00 3,631.50
Spencer A. Winters, P.C. 0.30 1,685.00 505.50
TOTALS 30.60 $ 55,069.00
2
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 118 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107365
Vyaire Medical Inc. Matter Number: 48520-29
Employee and Labor Matters
Description of Legal Services
Date Name Hours Description
09/04/24 Risa Salins 0.30 Correspond with C. Ceresa, K&E team,
AlixPartners re employment matter.
09/10/24 Chris Ceresa 0.30 Correspond with R. Salins and AlixPartners re
employment legal issues.
09/11/24 Chris Ceresa 1.60 Correspond with Company, R. Salins, K&E
team, and AlixPartners re employment legal
issues (.4); telephone conferences with R.
Salins, AlixPartners re issues re same (1.2).
09/11/24 Sooah Kim 0.70 Review, analyze 401(k) plan documents (.3);
conference with Company human resources
team (.4).
09/11/24 Risa Salins 1.00 Review, analyze employment matters
(.4); discuss same with C. Ceresa (.3);
telephone conference with P. Vasiloff re
research re same (.3).
09/12/24 Chris Ceresa 1.20 Telephone conferences with M. O'Brien,
AlixPartners re employment plan issues (1.1);
correspond with M. O’Brien, AlixPartners re
same (.1).
09/12/24 Sooah Kim 1.00 Conference with AlixPartners re
employee‑related issues (.6); review, analyze
401(k) plan documents (.1); conduct research
on safe harbor 401(k) plan requirements (.3).
09/12/24 Maureen D. O'Brien 1.50 Attend conference with C. Ceresa, K&E team
re 401(k) plans (.5); review, analyze plan
documents and applicable law (1.0).
09/12/24 Risa Salins 2.00 Review, analyze updated employee data (.3);
correspond with L. Harmon re same (.2);
review, analyze employment research from P.
Vasiloff and E. Davey (1.2); correspond with
P. Vasiloff re same (.3).
09/13/24 Chris Ceresa 0.50 Review, analyze /employee matter (.3);
correspond from AlixPartners re same (.2).
09/13/24 Risa Salins 1.80 Further review, analyze updated employee
data (.5); review, analyze further employment
matter research (.5); telephone conference
with AlixPartners re employee matters (.5);
correspond with P. Vasiloff re employee
matters, research re same (.3).
3
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 119 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107365
Vyaire Medical Inc. Matter Number: 48520-29
Employee and Labor Matters
Date Name Hours Description
09/16/24 Risa Salins 0.80 Conference with P. Vasiloff re employee
matters.
09/16/24 Paul Vasiloff 0.70 Draft updated employment‑related notice.
09/17/24 Luke Finn 0.50 Review, analyze employment issue.
09/17/24 Sooah Kim 0.20 Conduct research on safe harbor plans.
09/17/24 Risa Salins 0.50 Further review, analyze /employee matter
(.3); correspondence from AlixPartners re
same (.2).
09/18/24 Chris Ceresa 0.20 Correspond with R. Salins re open
employment planning issues.
09/18/24 Risa Salins 2.00 Review, analyze updated employee data
under employment statutes (1.5); correspond
with C. Ceresa, AlixPartners re same (.5).
09/19/24 Chris Ceresa 0.20 Correspond with R. Salins re open
employment planning issues.
09/19/24 Risa Salins 2.00 Telephone conference with E. Davey re
employment research (.3); review, analyze
research (.7); review, analyze further updated
employee/offer data (.5); telephone
conference with AlixPartners re employee
matters (.5).
09/20/24 Maureen D. O'Brien 0.50 Review, analyze safe harbor plan issues.
09/20/24 Risa Salins 0.50 Further review, analyze employee
offer/termination data.
09/21/24 Kate Hardey 0.70 Review and revise employee FAQs.
09/22/24 Jaina Desai 0.50 Correspond with Company re employment
issue.
09/22/24 Maureen D. O'Brien 0.50 Review, analyze benefits issues.
09/22/24 Spencer A. Winters, P.C. 0.30 Telephone conferences with AlixPartners, Y.
Salloum re employee issues.
09/23/24 Rebecca H. Arnall 0.80 Correspond with Y. Salloum re outstanding
severance issue.
09/23/24 Maureen D. O'Brien 1.00 Review, analyze benefit plan issues.
09/23/24 Risa Salins 1.00 Correspond with Y. Salloum, K&E team re
employee matters (.3); review and provide
comments to separation agreement (.7).
09/23/24 Paul Vasiloff 1.50 Review and provide comments to separation
agreement.
09/24/24 Rebecca H. Arnall 0.20 Correspond with Y. Salloum re outstanding
severance issue.
09/24/24 Chris Ceresa 0.20 Analyze legal issues re employment matters.
4
Case 24-11217-BLS Doc 758-2 Filed 11/20/24 Page 120 of 120
Legal Services for the Period Ending September 30, 2024 Invoice Number: 1050107365
Vyaire Medical Inc. Matter Number: 48520-29
Employee and Labor Matters
Date Name Hours Description
09/24/24 Luke Finn 0.30 Review, analyze employment issue.
09/24/24 Scott D. Price, P.C. 0.50 Review, analyze, discuss severance issues.
09/24/24 Risa Salins 0.30 Revise offer letters.
09/24/24 Paul Vasiloff 0.50 Correspond with Company correspondence re
employment issue.
09/28/24 Rebecca H. Arnall 0.50 Correspond with M. O’Brien re summary
severance plan (.3); review, analyze same
(.2).
09/28/24 Maureen D. O'Brien 1.00 Correspond with R. Arnall re severance plans.
09/29/24 Risa Salins 0.80 Review, analyze updated employee offer data
(.3); telephone conference with AlixPartners
re same (.5).
Total 30.60
5
File and source
- File
- gov.uscourts.deb.193283.758.2.pdf
- Size
- 3,144,440 bytes
- SHA-256
- 1b06fd03dd16d7f0aebf3526aabb2a859191cf747150fcacc6d3a88c1d1aea17
- Original
- PACER (login required)